<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CHRAC1 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>CHRAC1</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q9NRG0" target="_blank" class="term-link">
                        Q9NRG0
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "CHRAC1";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q9NRG0" data-a="DESCRIPTION: CHRAC1 (Chromatin Accessibility Complex protein 1,..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>CHRAC1 (Chromatin Accessibility Complex protein 1, also known as CHRAC-15 or CHRAC15) is a small (~15 kDa, 131 amino acids) histone-fold protein that functions as a structural/accessory subunit in the CHRAC (Chromatin Accessibility Complex) ATP-dependent chromatin remodeling complex. CHRAC1 forms a stable heterodimer with POLE3 (also known as CHRAC-17/p17) via their histone-fold domains, structurally analogous to the histone H2A-H2B dimer. This CHRAC1-POLE3 heterodimer binds naked double-stranded DNA and associates with the ACF chromatin remodeling complex (consisting of SMARCA5/SNF2H and BAZ1A/ACF1) to form the complete four-subunit CHRAC complex. The CHRAC1-POLE3 module enhances the ATP-dependent nucleosome sliding and chromatin assembly activities of ACF. CHRAC1 itself has no enzymatic activity but serves as an essential adapter that tethers the remodeling machinery to chromatin substrates. The complex functions in chromatin remodeling during DNA replication (particularly through heterochromatin), transcriptional regulation, and maintenance of chromatin organization.</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0005634" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 is a nuclear protein that functions in chromatin remodeling. The Human Protein Atlas confirms nuclear/nucleoplasm localization. UniProt states &#34;Nucleus&#34; for subcellular location. This is well-supported by its role as a subunit of the nuclear CHRAC chromatin remodeling complex [PMID:10880450].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Nuclear localization is strongly supported by CHRAC1&#39;s established role as a subunit of the CHRAC complex, which functions in the nucleus on chromatin. IBA inference is consistent with experimental data showing CHRAC1 is a chromatin-associated nuclear protein.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/CHRAC1/CHRAC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">CHRAC1 is an intracellular, nuclear protein. It lacks any signal peptides or transmembrane domains, and consistent with its role in chromatin dynamics, it localizes to the cell nucleus, predominantly in the nucleoplasm</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006261" target="_blank" class="term-link">
                                    GO:0006261
                                </a>
                            </span>
                            <span class="term-label">DNA-templated DNA replication</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0006261" data-r="GO_REF:0000033" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 is part of the CHRAC complex which facilitates DNA replication through heterochromatin by remodeling nucleosomes. The ACF1-ISWI complex (part of CHRAC) is required for DNA replication through pericentromeric heterochromatin [PMID:12434153]. However, CHRAC1 does not directly participate in DNA synthesis; it facilitates chromatin accessibility for the replication machinery.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While CHRAC1&#39;s complex facilitates DNA replication through chromatin, the term &#34;DNA-templated DNA replication&#34; implies direct involvement in DNA synthesis. CHRAC1 functions in chromatin remodeling to support replication, not in replication itself. A more accurate term would be &#34;regulation of DNA replication&#34; or chromatin remodeling during replication.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006275" target="_blank" class="term-link">
                                    regulation of DNA replication
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/12434153" target="_blank" class="term-link">
                                        PMID:12434153
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">an ACF1-ISWI chromatin-remodeling complex is required for replication through heterochromatin in mammalian cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006338" target="_blank" class="term-link">
                                    GO:0006338
                                </a>
                            </span>
                            <span class="term-label">chromatin remodeling</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0006338" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 is a core subunit of the CHRAC chromatin remodeling complex. The CHRAC1-POLE3 heterodimer enhances ATP-dependent nucleosome sliding and chromatin assembly mediated by ACF [PMID:14759371]. This is a primary function of CHRAC1.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Chromatin remodeling is the core function of the CHRAC complex of which CHRAC1 is an essential structural subunit. Multiple publications confirm CHRAC1&#39;s role in facilitating nucleosome sliding and chromatin reorganization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14759371" target="_blank" class="term-link">
                                        PMID:14759371
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">these histone-fold proteins facilitate ATP-dependent nucleosome sliding by ACF</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008623" target="_blank" class="term-link">
                                    GO:0008623
                                </a>
                            </span>
                            <span class="term-label">CHRAC</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0008623" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 is a defining component of the CHRAC (Chromatin Accessibility Complex). It was identified as part of HuCHRAC along with SMARCA5, BAZ1A, and POLE3 [PMID:10880450]. This is the eponymous complex for CHRAC1.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CHRAC1 is one of the four subunits that compose the CHRAC complex (along with SMARCA5/SNF2H, BAZ1A/ACF1, and POLE3). This cellular component annotation is directly supported by the original publication describing human CHRAC.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link">
                                        PMID:10880450
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the human homologues of two novel putative histone-fold proteins in Drosophila CHRAC are present in HuCHRAC</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003677" target="_blank" class="term-link">
                                    GO:0003677
                                </a>
                            </span>
                            <span class="term-label">DNA binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0003677" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 forms a heterodimer with POLE3 that binds naked double-stranded DNA. This is experimentally demonstrated in the original HuCHRAC characterization [PMID:10880450]. The annotation is correct but could be more specific.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While DNA binding is accurate, CHRAC1-POLE3 specifically binds double-stranded DNA, not nucleosomal DNA. A more specific term would be more informative, but this annotation is not incorrect.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link">
                                        PMID:10880450
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">two human histone-fold proteins form a stable complex that binds naked DNA but not nucleosomes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003887" target="_blank" class="term-link">
                                    GO:0003887
                                </a>
                            </span>
                            <span class="term-label">DNA-directed DNA polymerase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0003887" data-r="GO_REF:0000043" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 does NOT have DNA polymerase activity. This annotation is based on UniProt keyword mapping that is incorrect. CHRAC1 is a histone-fold structural protein with no catalytic activity. Its partner POLE3 is shared with DNA polymerase epsilon, but CHRAC1 itself is not a polymerase component.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is an erroneous annotation. CHRAC1 has no enzymatic activity and is not a DNA polymerase. The confusion likely arises because POLE3 (CHRAC1&#39;s binding partner) is also a subunit of DNA polymerase epsilon, but CHRAC1 is specific to the CHRAC complex and is not part of Pol epsilon.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14759371" target="_blank" class="term-link">
                                        PMID:14759371
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">CHRAC-17 interacts with another histone-fold protein, p12, in DNA polymerase epsilon, but CHRAC-15 is essential for interaction with ACF</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0005634" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate annotation of nuclear localization via UniProt subcellular location mapping. Correct annotation but redundant with the IBA annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Nuclear localization is accurate for CHRAC1. The duplicate evidence codes (IBA and IEA) both correctly identify the nuclear localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/CHRAC1/CHRAC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">CHRAC1 is an intracellular, nuclear protein</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016740" target="_blank" class="term-link">
                                    GO:0016740
                                </a>
                            </span>
                            <span class="term-label">transferase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0016740" data-r="GO_REF:0000043" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 does NOT have transferase activity. This is an erroneous annotation derived from incorrect UniProt keyword mapping. CHRAC1 is a non-enzymatic histone-fold protein that serves as a structural adapter in chromatin remodeling complexes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CHRAC1 has no catalytic activity whatsoever. It is a structural subunit that binds DNA and enhances the activity of the CHRAC complex&#39;s ATPase (SMARCA5), but has no enzymatic function itself. This annotation is completely incorrect.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016779" target="_blank" class="term-link">
                                    GO:0016779
                                </a>
                            </span>
                            <span class="term-label">nucleotidyltransferase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0016779" data-r="GO_REF:0000043" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 does NOT have nucleotidyltransferase activity. This annotation is erroneous, likely derived from the same incorrect keyword mapping that generated the DNA polymerase and transferase annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CHRAC1 is a non-enzymatic structural protein. It has no nucleotidyltransferase or any other enzymatic activity. This annotation should be removed as it misrepresents the function of CHRAC1.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0046982" target="_blank" class="term-link">
                                    GO:0046982
                                </a>
                            </span>
                            <span class="term-label">protein heterodimerization activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0046982" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 forms a stable heterodimer with POLE3 (CHRAC-17) via their histone-fold domains. This interaction is well-documented and essential for CHRAC1 function [PMID:10880450, PMID:14759371]. The annotation is accurate.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Heterodimerization with POLE3 is a core biochemical property of CHRAC1. The CHRAC1-POLE3 heterodimer is analogous to the H2A-H2B histone dimer and is essential for DNA binding and interaction with the ACF complex.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14759371" target="_blank" class="term-link">
                                        PMID:14759371
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">CHRAC-17 interacts with another histone-fold protein, p12, in DNA polymerase epsilon, but CHRAC-15 is essential for interaction with ACF</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0071897" target="_blank" class="term-link">
                                    GO:0071897
                                </a>
                            </span>
                            <span class="term-label">DNA biosynthetic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000108
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0071897" data-r="GO_REF:0000108" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 is not directly involved in DNA biosynthesis. This annotation appears to be derived from logical inference that is not accurate for CHRAC1&#39;s actual function. CHRAC1 facilitates chromatin remodeling during replication but does not participate in DNA synthesis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CHRAC1 does not synthesize DNA. While the CHRAC complex facilitates DNA replication by remodeling chromatin, CHRAC1 itself does not have any role in the actual biosynthesis of DNA. This annotation conflates the complex&#39;s role in supporting replication with direct participation in DNA synthesis.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/21516116" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:21516116
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Next-generation sequencing to generate interactome datasets.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0005515" data-r="PMID:21516116" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is from a large-scale interactome study. While CHRAC1 does bind proteins (POLE3, SMARCA5, BAZ1A), &#34;protein binding&#34; is too vague and uninformative for curation purposes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GO:0005515 (protein binding) is considered uninformative per GO curation guidelines. CHRAC1&#39;s specific protein interactions (heterodimerization with POLE3, interaction with ACF1/BAZ1A) are captured by more specific terms.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/21516116" target="_blank" class="term-link">
                                        PMID:21516116
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Next-generation sequencing to generate interactome datasets.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/25416956" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:25416956
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A proteome-scale map of the human interactome network.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0005515" data-r="PMID:25416956" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Large-scale proteome interactome study. The &#34;protein binding&#34; term is uninformative and should not be used for annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GO:0005515 (protein binding) is considered too vague per GO guidelines. High-throughput interactome studies do not provide sufficient specificity for meaningful functional annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/25416956" target="_blank" class="term-link">
                                        PMID:25416956
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">A proteome-scale map of the human interactome network.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31515488" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31515488
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Extensive disruption of protein interactions by genetic vari...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0005515" data-r="PMID:31515488" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Interactome study on genetic variants. The generic &#34;protein binding&#34; annotation is uninformative.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GO:0005515 (protein binding) should be avoided as it provides no specific functional information. CHRAC1&#39;s important protein interactions are better captured by heterodimerization activity and complex membership annotations.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31515488" target="_blank" class="term-link">
                                        PMID:31515488
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32296183
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A reference map of the human binary protein interactome.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0005515" data-r="PMID:32296183" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Binary protein interactome reference map study. Generic protein binding annotation is uninformative.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GO:0005515 should not be used for annotation. CHRAC1&#39;s specific binding partners and functions are already captured by more informative terms.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                                        PMID:32296183
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Apr 8. A reference map of the human binary protein interactome.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:33961781
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Dual proteome-scale networks reveal cell-specific remodeling...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0005515" data-r="PMID:33961781" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Dual proteome-scale interactome network study. Protein binding is uninformative as a molecular function annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GO:0005515 (protein binding) provides no specific functional insight. This generic term should be replaced by more specific molecular function terms that describe CHRAC1&#39;s actual interactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link">
                                        PMID:33961781
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">2021 May 6. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005721" target="_blank" class="term-link">
                                    GO:0005721
                                </a>
                            </span>
                            <span class="term-label">pericentric heterochromatin</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0005721" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> The CHRAC complex (containing CHRAC1) localizes to pericentric heterochromatin during late S phase when this region is replicated. ACF1 and SNF2H colocalize with heterochromatin and BrdU during S phase [PMID:12434153].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CHRAC1 is part of the CHRAC complex which is specifically recruited to pericentromeric heterochromatin during DNA replication. This localization is functionally relevant for CHRAC&#39;s role in facilitating replication through condensed chromatin.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/12434153" target="_blank" class="term-link">
                                        PMID:12434153
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">ACF1 (ATP-utilizing chromatin assembly and remodeling factor 1) and an ISWI isoform, SNF2H (sucrose nonfermenting-2 homolog), become specifically enriched in replicating pericentromeric heterochromatin</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005721" target="_blank" class="term-link">
                                    GO:0005721
                                </a>
                            </span>
                            <span class="term-label">pericentric heterochromatin</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISO</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000114
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0005721" data-r="GO_REF:0000114" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Manual transfer of heterochromatin localization from homologous complexes. This is consistent with CHRAC&#39;s established role in heterochromatin replication.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Pericentric heterochromatin localization is supported by experimental data for the CHRAC complex, making this ISO annotation well-justified. The complex is enriched at heterochromatin during late S-phase replication.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/12434153" target="_blank" class="term-link">
                                        PMID:12434153
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">RNAi-mediated depletion of ACF1 specifically impairs the replication of pericentromeric heterochromatin</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006275" target="_blank" class="term-link">
                                    GO:0006275
                                </a>
                            </span>
                            <span class="term-label">regulation of DNA replication</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/12434153" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:12434153
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    An ACF1-ISWI chromatin-remodeling complex is required for DN...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0006275" data-r="PMID:12434153" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is based on the study showing that depletion of ACF1 (CHRAC component) impairs replication of pericentromeric heterochromatin and delays cell cycle progression through late S phase [PMID:12434153]. CHRAC1 is part of this complex.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The CHRAC complex, of which CHRAC1 is a subunit, regulates DNA replication by facilitating replication through heterochromatin. Loss of complex components leads to replication defects, demonstrating a regulatory role.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/12434153" target="_blank" class="term-link">
                                        PMID:12434153
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">depletion of ACF1 causes a delay in cell-cycle progression through the late stages of S phase</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006334" target="_blank" class="term-link">
                                    GO:0006334
                                </a>
                            </span>
                            <span class="term-label">nucleosome assembly</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/14759371" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:14759371
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The histone-fold protein complex CHRAC-15/17 enhances nucleo...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0006334" data-r="PMID:14759371" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CHRAC1 (as part of the CHRAC1-POLE3 complex) facilitates chromatin assembly mediated by ACF. The study shows that CHRAC-15/17, p12/CHRAC-17, and NC2 complexes facilitate ACF-mediated chromatin assembly [PMID:14759371].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Nucleosome assembly is a core function of the CHRAC complex. The CHRAC1-POLE3 heterodimer enhances the chromatin assembly activity of ACF, making this a valid molecular function of CHRAC1.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14759371" target="_blank" class="term-link">
                                        PMID:14759371
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">CHRAC-15/17, p12/CHRAC-17, and NC2 complexes facilitate ACF-mediated chromatin assembly by a mechanism different from nucleosome sliding enhancement</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006338" target="_blank" class="term-link">
                                    GO:0006338
                                </a>
                            </span>
                            <span class="term-label">chromatin remodeling</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10880450
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    HuCHRAC, a human ISWI chromatin remodelling complex contains...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0006338" data-r="PMID:10880450" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> The original publication identifying HuCHRAC demonstrates that this complex has ATP-dependent chromatin remodeling activity. CHRAC1 is an essential subunit of this complex [PMID:10880450].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Chromatin remodeling is the defining function of the CHRAC complex. This IDA annotation from the original characterization paper is well-supported.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link">
                                        PMID:10880450
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008623" target="_blank" class="term-link">
                                    GO:0008623
                                </a>
                            </span>
                            <span class="term-label">CHRAC</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10880450
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    HuCHRAC, a human ISWI chromatin remodelling complex contains...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0008623" data-r="PMID:10880450" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This NAS annotation for CHRAC complex membership is from the same publication that identified HuCHRAC. While NAS is a weaker evidence code, the data clearly supports CHRAC1 as a CHRAC subunit.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CHRAC1 is definitionally a component of the CHRAC complex - it is named for this complex (CHRAC-15). The original publication provides direct evidence for this complex membership.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link">
                                        PMID:10880450
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the human homologues of two novel putative histone-fold proteins in Drosophila CHRAC are present in HuCHRAC</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003887" target="_blank" class="term-link">
                                    GO:0003887
                                </a>
                            </span>
                            <span class="term-label">DNA-directed DNA polymerase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10880450
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    HuCHRAC, a human ISWI chromatin remodelling complex contains...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0003887" data-r="PMID:10880450" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This NAS annotation is INCORRECT. PMID:10880450 does not claim that CHRAC1 has DNA polymerase activity. The publication describes CHRAC1 as a histone-fold protein in a chromatin remodeling complex, not as an enzyme.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is erroneous. CHRAC1 has no DNA polymerase activity. The original publication (PMID:10880450) describes CHRAC1 as a structural histone-fold protein, not an enzyme. The confusion may arise from POLE3&#39;s dual role in Pol epsilon, but CHRAC1 is not part of the polymerase complex.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14759371" target="_blank" class="term-link">
                                        PMID:14759371
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">CHRAC-17 interacts with another histone-fold protein, p12, in DNA polymerase epsilon, but CHRAC-15 is essential for interaction with ACF</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link">
                                        PMID:10880450
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008622" target="_blank" class="term-link">
                                    GO:0008622
                                </a>
                            </span>
                            <span class="term-label">epsilon DNA polymerase complex</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10880450
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    HuCHRAC, a human ISWI chromatin remodelling complex contains...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0008622" data-r="PMID:10880450" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is INCORRECT. CHRAC1 is NOT a component of DNA polymerase epsilon. POLE3 (CHRAC1&#39;s binding partner) is shared between CHRAC and Pol epsilon, but CHRAC1 itself is specific to the CHRAC complex [PMID:14759371].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CHRAC1 is not a subunit of DNA polymerase epsilon. While POLE3 (p17) is shared between CHRAC and Pol epsilon, CHRAC1 (p15) is unique to CHRAC. The original literature clearly distinguishes CHRAC1 from Pol epsilon components.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/14759371" target="_blank" class="term-link">
                                        PMID:14759371
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">CHRAC-17 interacts with another histone-fold protein, p12, in DNA polymerase epsilon, but CHRAC-15 is essential for interaction with ACF</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link">
                                        PMID:10880450
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003677" target="_blank" class="term-link">
                                    GO:0003677
                                </a>
                            </span>
                            <span class="term-label">DNA binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10880450
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    HuCHRAC, a human ISWI chromatin remodelling complex contains...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0003677" data-r="PMID:10880450" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> DNA binding is demonstrated for the CHRAC1-POLE3 heterodimer in the original publication. The complex binds naked DNA but not nucleosomes [PMID:10880450].
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> DNA binding is experimentally demonstrated for the CHRAC1-containing heterodimer. While a more specific term (double-stranded DNA binding) would be preferable, the NAS annotation accurately reflects CHRAC1&#39;s DNA-binding capability.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link">
                                        PMID:10880450
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">two human histone-fold proteins form a stable complex that binds naked DNA but not nucleosomes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006338" target="_blank" class="term-link">
                                    GO:0006338
                                </a>
                            </span>
                            <span class="term-label">chromatin remodeling</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10880450
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    HuCHRAC, a human ISWI chromatin remodelling complex contains...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9NRG0" data-a="GO:0006338" data-r="PMID:10880450" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate annotation of chromatin remodeling with NAS evidence. Already covered by IBA and IDA annotations for the same term.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While redundant with other evidence codes, this annotation correctly reflects CHRAC1&#39;s role in chromatin remodeling as a CHRAC complex subunit.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link">
                                        PMID:10880450
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>CHRAC1 forms a stable heterodimer with POLE3 via their histone-fold domains. This dimerization is analogous to H2A-H2B and is essential for DNA binding and interaction with the ACF complex [PMID:10880450, PMID:14759371].</h3>
                <span class="vote-buttons" data-g="Q9NRG0" data-a="FUNCTION: CHRAC1 forms a stable heterodimer with POLE3 via t..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0046982" target="_blank" class="term-link">
                            protein heterodimerization activity
                        </a>
                    </span>
                </div>
                

                

                

                
                <div class="function-term-group">
                    <div class="function-term-label">In Complex:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008623" target="_blank" class="term-link">
                            CHRAC
                        </a>
                    </span>
                </div>
                

                
            </div>

            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>The CHRAC1-POLE3 heterodimer binds naked double-stranded DNA but not nucleosomes. This DNA-binding capability is essential for tethering the remodeling complex to chromatin [PMID:10880450].</h3>
                <span class="vote-buttons" data-g="Q9NRG0" data-a="FUNCTION: The CHRAC1-POLE3 heterodimer binds naked double-st..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003677" target="_blank" class="term-link">
                            DNA binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006338" target="_blank" class="term-link">
                                chromatin remodeling
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                nucleus
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">In Complex:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008623" target="_blank" class="term-link">
                            CHRAC
                        </a>
                    </span>
                </div>
                

                
            </div>

            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000108.md" target="_blank" class="term-link">
                            GO_REF:0000108
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic assignment of GO terms using logical inference, based on inter-ontology links.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000114.md" target="_blank" class="term-link">
                            GO_REF:0000114
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Manual transfer of experimentally-verified manual GO annotation data to homologous complexes by curator judgment of sequence, composition and function similarity</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10880450" target="_blank" class="term-link">
                            PMID:10880450
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">The paper identifies human CHRAC (HuCHRAC) containing SMARCA5/SNF2H, BAZ1A/ACF1, CHRAC1 (p15), and POLE3 (p17)</div>
                        
                        <div class="finding-text">"the human homologues of two novel putative histone-fold proteins in Drosophila CHRAC are present in HuCHRAC"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">CHRAC1 and POLE3 form a stable heterodimer that binds naked DNA but not nucleosomes</div>
                        
                        <div class="finding-text">"two human histone-fold proteins form a stable complex that binds naked DNA but not nucleosomes"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">The complex has ATP-dependent chromatin remodeling activity</div>
                        
                        <div class="finding-text">"HuCHRAC, a human ISWI chromatin remodelling complex"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">CHRAC1 is a histone-fold protein, not an enzyme</div>
                        
                        <div class="finding-text">"two novel putative histone-fold proteins in Drosophila CHRAC are present in HuCHRAC"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/12434153" target="_blank" class="term-link">
                            PMID:12434153
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">An ACF1-ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ACF1-ISWI complex is required for replication through pericentromeric heterochromatin</div>
                        
                        <div class="finding-text">"an ACF1-ISWI chromatin-remodeling complex is required for replication through heterochromatin in mammalian cells"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">ACF1 and SNF2H become enriched in replicating pericentromeric heterochromatin</div>
                        
                        <div class="finding-text">"ACF1 (ATP-utilizing chromatin assembly and remodeling factor 1) and an ISWI isoform, SNF2H (sucrose nonfermenting-2 homolog), become specifically enriched in replicating pericentromeric heterochromatin"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Depletion of ACF1 causes cell cycle delay in late S phase</div>
                        
                        <div class="finding-text">"depletion of ACF1 causes a delay in cell-cycle progression through the late stages of S phase"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/14759371" target="_blank" class="term-link">
                            PMID:14759371
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The histone-fold protein complex CHRAC-15/17 enhances nucleosome sliding and assembly mediated by ACF.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">CHRAC-15/17 (CHRAC1/POLE3) facilitates ATP-dependent nucleosome sliding by ACF</div>
                        
                        <div class="finding-text">"these histone-fold proteins facilitate ATP-dependent nucleosome sliding by ACF"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Direct interaction of CHRAC-15/17 with ACF1 is essential for nucleosome sliding</div>
                        
                        <div class="finding-text">"Direct interaction of the CHRAC-15/17 complex with the ACF1 subunit is essential for this process"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">CHRAC-15 (CHRAC1) is essential for interaction with ACF</div>
                        
                        <div class="finding-text">"CHRAC-15 is essential for interaction with ACF and enhancement of nucleosome sliding"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">CHRAC-17 (POLE3) also interacts with p12 (POLE4) in DNA polymerase epsilon</div>
                        
                        <div class="finding-text">"CHRAC-17 interacts with another histone-fold protein, p12, in DNA polymerase epsilon"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">CHRAC-15/17 facilitates chromatin assembly by a mechanism different from sliding</div>
                        
                        <div class="finding-text">"CHRAC-15/17, p12/CHRAC-17, and NC2 complexes facilitate ACF-mediated chromatin assembly by a mechanism different from nucleosome sliding enhancement"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21516116" target="_blank" class="term-link">
                            PMID:21516116
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Next-generation sequencing to generate interactome datasets.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25416956" target="_blank" class="term-link">
                            PMID:25416956
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A proteome-scale map of the human interactome network.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31515488" target="_blank" class="term-link">
                            PMID:31515488
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                            PMID:32296183
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A reference map of the human binary protein interactome.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link">
                            PMID:33961781
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/CHRAC1/CHRAC1-deep-research-openai.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research review of CHRAC1</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">CHRAC1 is a nuclear protein localizing to the nucleoplasm</div>
                        
                        <div class="finding-text">"CHRAC1 is an intracellular, nuclear protein. It lacks any signal peptides or transmembrane domains, and consistent with its role in chromatin dynamics, it localizes to the cell nucleus, predominantly in the nucleoplasm"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/CHRAC1/CHRAC1-deep-research-cyberian.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Cyberian deep research on CHRAC1 function</div>
                
                
            </div>
            
        </div>
    </div>
    


    
    <div class="section">
        <h2 class="section-title">Suggested Questions for Experts</h2>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Does CHRAC1 have any independent function outside of its role in the CHRAC complex?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9NRG0" data-a="Q: Does CHRAC1 have any independent function outside ..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the precise stoichiometry of CHRAC1 in the CHRAC complex?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9NRG0" data-a="Q: What is the precise stoichiometry of CHRAC1 in the..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Are there tissue-specific or developmental roles for CHRAC1?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9NRG0" data-a="Q: Are there tissue-specific or developmental roles f..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Suggested Experiments</h2>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Structural studies (cryo-EM) of the complete CHRAC complex to understand CHRAC1&#39;s precise positioning and interactions</p>
                    
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q9NRG0" data-a="EXPERIMENT: Structural studies (cryo-EM) of the complete CHRAC..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> CHRAC1-specific knockout/knockdown studies to distinguish its function from other complex components</p>
                    
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q9NRG0" data-a="EXPERIMENT: CHRAC1-specific knockout/knockdown studies to dist..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> ChIP-seq of CHRAC1 to map genome-wide binding sites</p>
                    
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q9NRG0" data-a="EXPERIMENT: ChIP-seq of CHRAC1 to map genome-wide binding site..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Cyberian</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(CHRAC1-deep-research-cyberian.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9NRG0" data-a="DOC: Deep Research Cyberian" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: cyberian<br />
model: deep-research<br />
cached: false<br />
start_time: '2026-01-21T21:34:18.269897'<br />
end_time: '2026-01-21T21:48:41.409586'<br />
duration_seconds: 863.14<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: CHRAC1<br />
  gene_symbol: CHRAC1<br />
  uniprot_accession: Q9NRG0<br />
  protein_description: 'RecName: Full=Chromatin accessibility complex protein 1; Short=CHRAC-1;<br />
    AltName: Full=Chromatin accessibility complex 15 kDa protein; Short=CHRAC-15;<br />
    Short=HuCHRAC15; AltName: Full=DNA polymerase epsilon subunit p15;'<br />
  gene_info: Name=CHRAC1; Synonyms=CHRAC15;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg.<br />
    (IPR050568); CBFD_NFYB_HMF (PF00808)<br />
provider_config:<br />
  timeout: 1800<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    agent_type: claude<br />
    port: 3284<br />
    skip_permissions: true<br />
citation_count: 14</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9NRG0</li>
<li><strong>Protein Description:</strong> RecName: Full=Chromatin accessibility complex protein 1; Short=CHRAC-1; AltName: Full=Chromatin accessibility complex 15 kDa protein; Short=CHRAC-15; Short=HuCHRAC15; AltName: Full=DNA polymerase epsilon subunit p15;</li>
<li><strong>Gene Information:</strong> Name=CHRAC1; Synonyms=CHRAC15;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg. (IPR050568); CBFD_NFYB_HMF (PF00808)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "CHRAC1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'CHRAC1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>CHRAC1</strong> (gene ID: CHRAC1, UniProt: Q9NRG0) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="chrac1-chromatin-accessibility-complex-protein-1-a-comprehensive-review">CHRAC1 (Chromatin Accessibility Complex Protein 1): A Comprehensive Review</h1>
<h2 id="introduction">Introduction</h2>
<p>CHRAC1 (Chromatin Accessibility Complex Subunit 1), also known as CHRAC-15, HuCHRAC15, or YCL1, is a small histone-fold protein that functions as an essential component of the chromatin accessibility complex (CHRAC) in humans. Encoded by the CHRAC1 gene (gene ID: 54108) located on chromosome 8q24.3, this 131 amino acid protein (UniProt: Q9NRG0) plays a critical role in ATP-dependent chromatin remodeling by facilitating nucleosome sliding and assembly. CHRAC1 forms a stable heterodimer with POLE3 (CHRAC-17/p17) that binds DNA in a sequence-independent manner and integrates into larger chromatin remodeling complexes. Through its interactions with the ISWI-family ATPase SMARCA5/SNF2H and the regulatory subunit BAZ1A/ACF1, CHRAC1 participates in fundamental nuclear processes including DNA replication, transcriptional regulation, and chromatin organization [poot-2000-huchrac-abstract][kukimoto-2004-chrac15-17-sliding-abstract].</p>
<p>The identification of CHRAC1 emerged from studies of chromatin remodeling complexes in Drosophila melanogaster, where the chromatin accessibility complex was first discovered as an ATP-dependent machine capable of increasing DNA accessibility within chromatin [vargaweisz-1997-chrac-nature-abstract]. Subsequent work by Poot and colleagues in 2000 characterized the human homolog, HuCHRAC, and identified two novel histone-fold proteins, p15 (CHRAC1) and p17 (POLE3), as conserved subunits [poot-2000-huchrac-abstract]. This evolutionary conservation from insects to humans underscores the fundamental importance of CHRAC1 in chromatin biology.</p>
<h2 id="protein-structure-and-domain-architecture">Protein Structure and Domain Architecture</h2>
<p>CHRAC1 is a relatively small protein consisting of 131 amino acids with an apparent molecular mass of approximately 15 kDa as determined by SDS-PAGE analysis [poot-2000-huchrac-abstract]. The protein contains a central histone-fold domain (HFD) of approximately 65 amino acids, flanked by short N-terminal and C-terminal regions that are enriched in acidic and lysine residues [bolognese-2000-ybl1-ycl1-abstract]. The histone-fold domain of CHRAC1 is classified as an H2A-type fold, showing significant similarity to the HFD found in NFYC (NF-YC, CBFC), a subunit of the CCAAT-binding transcription factor NF-Y [corona-2000-chrac14-16-abstract][gnesutta-2013-hfd-proteins-abstract].</p>
<p>The crystal structure of the Drosophila CHRAC14-CHRAC16 heterodimer (homologs of human POLE3 and CHRAC1, respectively) was determined at 2.4-Angstrom resolution by Hartlepp and colleagues in 2005 (PDB: 2BYM) [hartlepp-2005-structure-mechanism-abstract]. This structure revealed that the two proteins dimerize via a variant histone fold in a characteristic "handshake" configuration, directly analogous to the H2A-H2B histone pair within the nucleosome. The heterodimer contains unstructured N- and C-terminal tail domains that protrude from the handshake structure, reminiscent of histone tails. Importantly, deletion of the negatively charged C-terminus of CHRAC-16 (the fly homolog of CHRAC1) enhances DNA binding 25-fold but paradoxically inhibits nucleosome sliding, suggesting that these terminal regions play crucial regulatory roles in balancing DNA binding affinity with functional activity [hartlepp-2005-structure-mechanism-abstract].</p>
<p>Despite sharing only 15-18% sequence identity with core histones H2A and H2B, CHRAC1 and related histone-fold domain proteins share highly conserved tertiary structures [gnesutta-2013-hfd-proteins-abstract]. The CHRAC1 HFD shows 25-35% sequence identity with other H2A-type HFD proteins including NC2alpha, NF-YC, and CHRAC-16, which is considerably higher than the identity with canonical histones. This structural conservation enables the CHRAC1-POLE3 heterodimer to function in a manner analogous to DNA chaperones, providing transient acceptor sites for DNA during the nucleosome remodeling process.</p>
<h2 id="molecular-function-facilitation-of-nucleosome-sliding-and-assembly">Molecular Function: Facilitation of Nucleosome Sliding and Assembly</h2>
<p>The primary molecular function of CHRAC1 is to facilitate ATP-dependent nucleosome sliding and chromatin assembly as a component of the CHRAC complex. This function was definitively established through biochemical studies by Kukimoto and colleagues in 2004, who demonstrated that the CHRAC-15/17 (CHRAC1/POLE3) heterodimer enhances nucleosome sliding mediated by the ACF complex (ACF1-ISWI) [kukimoto-2004-chrac15-17-sliding-abstract]. The direct interaction between CHRAC-15/17 and ACF1 is essential for this enhancement, and notably, CHRAC-15 (CHRAC1) specifically is required for the interaction with ACF and the resulting enhancement of nucleosome sliding activity.</p>
<p>The mechanism by which CHRAC1 facilitates nucleosome sliding involves low-affinity, sequence-independent DNA binding. The CHRAC1-POLE3 heterodimer binds naked DNA with submicromolar affinity but does not bind to nucleosomes directly [poot-2000-huchrac-abstract]. This DNA binding activity is thought to provide a transient acceptor site for DNA that is being displaced from the histone surface during the sliding reaction [hartlepp-2005-structure-mechanism-abstract]. Analysis of the DNA binding properties suggests that CHRAC1-POLE3 functions analogously to the DNA chaperone HMGB1 in facilitating nucleosome remodeling, where dynamic, low-affinity DNA interactions improve the efficiency of nucleosome mobilization [hartlepp-2005-structure-mechanism-abstract].</p>
<p>Mechanistically, CHRAC induces movements of intact histone octamers to neighboring DNA segments without disrupting the octamer or displacing histones to competing DNA in trans [langst-1999-nucleosome-movement-abstract]. This nucleosome sliding activity is ATP-dependent and requires the catalytic activity of the ISWI ATPase (SMARCA5/SNF2H in humans). Importantly, the directionality of nucleosome sliding differs between CHRAC and ISWI alone, indicating that the accessory subunits including CHRAC1 modulate the activity of the ATPase motor [langst-1999-nucleosome-movement-abstract].</p>
<p>Beyond nucleosome sliding, CHRAC1 also participates in chromatin assembly reactions. The CHRAC-15/17 complex facilitates ACF-mediated chromatin assembly, converting irregular chromatin into regular arrays of nucleosomes with even spacing [vargaweisz-1997-chrac-nature-abstract][kukimoto-2004-chrac15-17-sliding-abstract]. Interestingly, this chromatin assembly activity occurs through a mechanism distinct from nucleosome sliding enhancement, suggesting that CHRAC1 has multiple functional modes in chromatin dynamics.</p>
<h2 id="the-chrac-complex-composition-and-organization">The CHRAC Complex: Composition and Organization</h2>
<p>The complete human CHRAC (HuCHRAC) complex consists of four core subunits: SMARCA5/SNF2H (the ISWI ATPase), BAZ1A/ACF1 (the regulatory subunit), CHRAC1/CHRAC-15 (p15), and POLE3/CHRAC-17 (p17) [poot-2000-huchrac-abstract]. SMARCA5 provides the ATP-dependent motor activity that drives nucleosome sliding, while ACF1 contains multiple functional domains including WAC, DDT, WAKZ, PHD finger, and bromodomain motifs that regulate nucleosome interactions and targeting [fyodorov-2004-acf1-chromatin-abstract]. The CHRAC1-POLE3 heterodimer binds DNA and enhances the efficiency of the remodeling reaction.</p>
<p>The evolutionary conservation of this complex is remarkable. In Drosophila, CHRAC contains ISWI, Acf1, CHRAC-14 (homolog of POLE3), and CHRAC-16 (homolog of CHRAC1) [corona-2000-chrac14-16-abstract]. Notably, Drosophila CHRAC also contains topoisomerase II as a fifth subunit, which was not found in human CHRAC [vargaweisz-1997-chrac-nature-abstract][poot-2000-huchrac-abstract]. This compositional difference may reflect species-specific functional requirements.</p>
<p>CHRAC is closely related to but distinct from the ACF complex, which contains only SMARCA5 and ACF1 without the histone-fold subunits [fyodorov-2004-acf1-chromatin-abstract]. The presence of CHRAC1 and POLE3 in CHRAC distinguishes it from ACF and confers enhanced nucleosome sliding activity. Both complexes participate in chromatin assembly and remodeling, but CHRAC appears to be particularly important for efficient nucleosome mobilization under conditions of limiting enzyme concentrations [hartlepp-2005-structure-mechanism-abstract].</p>
<h2 id="dual-identity-chrac-subunit-and-dna-polymerase-epsilon-component">Dual Identity: CHRAC Subunit and DNA Polymerase Epsilon Component</h2>
<p>A remarkable feature of the CHRAC histone-fold subunits is their dual localization in distinct macromolecular complexes. POLE3 (CHRAC-17/p17) was independently identified as a subunit of human DNA polymerase epsilon [li-2000-pole3-pole4-abstract]. Within the polymerase epsilon complex, POLE3 forms a heterodimer with POLE4 (p12), and this heterodimer is required for interaction with the catalytic subunit POLE1 (p261) and the accessory subunit POLE2 (p59) [li-2000-pole3-pole4-abstract]. This dual residence of POLE3 in both chromatin remodeling (with CHRAC1) and DNA replication (with POLE4) machineries suggests functional coordination between these processes.</p>
<p>CHRAC1 also interacts with POLE3 in the context of the DNA polymerase epsilon complex pathway, though its role there is less well characterized than in CHRAC [bolognese-2000-ybl1-ycl1-abstract]. The ability of these histone-fold proteins to participate in multiple complexes reflects the modular nature of chromatin-associated machinery and suggests that CHRAC1 may coordinate chromatin remodeling with DNA replication at a molecular level.</p>
<h2 id="subcellular-localization">Subcellular Localization</h2>
<p>CHRAC1 localizes to the nucleus, consistent with its function in chromatin remodeling. According to the Human Protein Atlas, the protein is specifically localized to the nucleoplasm. Based on ortholog data and functional studies, CHRAC1 is also found at pericentromeric heterochromatin regions [fyodorov-2004-acf1-chromatin-abstract]. This heterochromatic localization is functionally significant, as the ACF1-containing complexes (including CHRAC) have been implicated in heterochromatin formation and maintenance.</p>
<p>The targeting of CHRAC to specific chromatin regions appears to be mediated primarily through the ACF1 subunit, which contains multiple chromatin-reading domains including a PHD finger and bromodomain. ACF1 specifically targets heterochromatin through its N-terminal region, and the CHRAC1-containing complex accumulates at sites of pericentromeric heterochromatin replication during S phase.</p>
<h2 id="biological-processes-and-pathways">Biological Processes and Pathways</h2>
<h3 id="dna-replication">DNA Replication</h3>
<p>CHRAC participates in DNA replication by facilitating access of the replication machinery to chromatin-covered origins and by promoting replication through condensed chromatin regions. The pioneering study by Alexiadis and colleagues demonstrated that CHRAC could facilitate initiation of SV40 DNA replication from a nucleosomal origin by enabling T-antigen access to chromatin-covered sequences [alexiadis-1998-sv40-replication-abstract]. This finding established a direct role for chromatin remodeling in DNA replication initiation.</p>
<p>In Drosophila, loss of ACF1 (which disrupts both ACF and CHRAC complexes) results in accelerated progression through S phase, consistent with reduced chromatin-mediated repression of DNA replication [fyodorov-2004-acf1-chromatin-abstract]. The ACF1-SMARCA5 complex is specifically enriched in replicating pericentromeric heterochromatin, and depletion of ACF1 by RNA interference specifically impairs heterochromatin replication. These findings indicate that CHRAC1, as part of the CHRAC complex, facilitates the replication of heterochromatic regions that would otherwise present a barrier to the replication fork.</p>
<h3 id="chromatin-organization-and-gene-silencing">Chromatin Organization and Gene Silencing</h3>
<p>CHRAC1 participates in establishing and maintaining organized chromatin structure. The ACF/CHRAC complexes promote the formation of repressive chromatin by generating regularly spaced nucleosome arrays from irregular chromatin [vargaweisz-1997-chrac-nature-abstract][fyodorov-2004-acf1-chromatin-abstract]. Loss of ACF1 in Drosophila results in decreased periodicity of nucleosome arrays and shorter nucleosomal repeat length in bulk chromatin, demonstrating the importance of these complexes in chromatin organization.</p>
<p>Genetically, ACF1 (and by extension CHRAC) contributes to transcriptional silencing in pericentromeric heterochromatin and in regions regulated by Polycomb group proteins [fyodorov-2004-acf1-chromatin-abstract]. The CHRAC/ACF complexes have been described as contributing to the "repressive ground state of chromatin," establishing an inactive baseline from which gene expression must be activated.</p>
<h3 id="dna-repair">DNA Repair</h3>
<p>Components of the CHRAC complex, particularly SMARCA5/SNF2H and ACF1, have been implicated in DNA repair pathways. Recent studies have elucidated the mechanism by which the ACF complex is recruited to sites of DNA damage. ADP-ribosylation signaling, which marks sites of DNA lesions, orchestrates the recruitment of various repair factors and chromatin remodeling complexes during the early stages of the DNA damage response. The ACF complex accumulates at DNA lesions in an ADP-ribosylation-dependent manner, though interestingly, each subunit (SMARCA5 and ACF1) accumulates independently from its partner. The recruitment of these proteins is not due to direct binding to ADP-ribose moieties but rather results from facilitated DNA binding at relaxed, ADP-ribosylated chromatin. ACF1 and SMARCA5 facilitate both nucleotide excision repair and transcription-coupled nucleotide excision repair (TC-NER) following UV irradiation. While the specific contribution of CHRAC1 to DNA repair has not been extensively characterized, its role in enhancing the nucleosome sliding activity of the CHRAC complex suggests participation in repair-associated chromatin remodeling that facilitates access of repair machinery to damaged DNA.</p>
<h2 id="expression-pattern">Expression Pattern</h2>
<p>Northern blot analysis revealed that CHRAC1 is expressed ubiquitously across human tissues, producing a 2.4-kb transcript [poot-2000-huchrac-abstract]. The expression pattern of CHRAC1 parallels that of its heterodimer partner POLE3 (CHRAC-17), suggesting coordinated regulation of these functionally linked genes. According to the Human Protein Atlas, CHRAC1 shows low tissue specificity, with expression detected in virtually all major tissue types.</p>
<p>The highest expression levels are observed in bone marrow (26.4 nTPM), skeletal muscle (26.1 nTPM), tonsil (24.5 nTPM), and blood vessel (22.3 nTPM). In the brain, white matter shows the highest regional expression (32.2 nTPM). At the single-cell level, early primary spermatocytes show exceptionally high CHRAC1 expression (91.8 nCPM), potentially reflecting the intense chromatin remodeling activity required during meiosis. This is consistent with the recently described essential role of SMARCA5 in male meiosis and fertility.</p>
<h2 id="evolutionary-conservation">Evolutionary Conservation</h2>
<p>CHRAC1 is highly conserved across metazoan species, reflecting the fundamental importance of the CHRAC complex in chromatin biology. The Drosophila homolog CHRAC-16 shows significant sequence conservation with human CHRAC1, particularly within the histone-fold domain. Both proteins share the H2A-type HFD structure and the ability to heterodimerize with their POLE3/CHRAC-14 partners [corona-2000-chrac14-16-abstract].</p>
<p>The conservation extends beyond the histone-fold motif to include the N- and C-terminal regions, suggesting functional importance for these apparently unstructured domains [bolognese-2000-ybl1-ycl1-abstract]. The yeast ISW2 chromatin remodeling complex also contains a pair of histone-fold proteins, indicating that this organization of chromatin remodeling complexes predates the divergence of fungi and animals.</p>
<h2 id="disease-associations-and-therapeutic-implications">Disease Associations and Therapeutic Implications</h2>
<p>Recent studies have revealed significant associations between CHRAC1 and cancer progression, particularly through its interaction with the Hippo pathway effector YAP. Wang and colleagues in 2022 demonstrated that CHRAC1 is highly expressed in lung cancer tissues, and this elevated expression correlates with poor prognosis in lung cancer patients [wang-2022-chrac1-lung-cancer-abstract]. Their functional studies showed that CHRAC1 overexpression promotes lung cancer cell proliferation and migration both in vitro and in vivo using a genetically engineered KrasG12D.LSL lung adenocarcinoma mouse model. Conversely, CHRAC1 silencing inhibited cell proliferation, migration, and tumor growth in xenograft models. Mechanistically, CHRAC1 binds to YAP and enhances the transcription of downstream oncogenic targets in the Hippo pathway, thereby promoting tumor growth [wang-2022-chrac1-lung-cancer-abstract].</p>
<p>These findings were extended by Li and colleagues in 2024, who demonstrated that CHRAC1 promotes tumor growth in breast and cervical cancer through the same YAP-mediated mechanism [li-2024-chrac1-cancer-abstract]. CHRAC1 depletion suppressed cancer cell proliferation and tumor growth, while elevated CHRAC1 expression correlated with worse patient outcomes, advanced disease stages, and metastasis. The interaction between CHRAC1 and YAP appears to be indirect and may be mediated by other components of the CHRAC complex, such as ACF1 or SMARCA5, consistent with the relatively small size of CHRAC1 (15 kDa).</p>
<p>Analysis of The Cancer Genome Atlas (TCGA) data has revealed that CHRAC1, along with its complex partners BAZ1A and POLE3, is simultaneously upregulated in multiple tumor types including esophageal carcinoma, liver hepatocellular carcinoma, stomach adenocarcinoma, and breast invasive carcinoma [zhou-2021-iswi-cancer-review-summary]. The CHRAC1 gene is located on chromosome 8q24.3, a region frequently amplified in cancer, and has been identified as a driver gene promoting proliferation and clonal survival of breast cancer cells.</p>
<p>More broadly, the ISWI chromatin remodeling complexes including CHRAC have been implicated in various cancers. SMARCA5, the catalytic subunit of CHRAC, is upregulated in acute myeloid leukemia and has been linked to breast, lung, and gastric cancers [zhou-2021-iswi-cancer-review-summary]. The emerging understanding of CHRAC1's role in cancer, particularly its function as a YAP coactivator, suggests it may represent a potential therapeutic target, though further research is needed to fully characterize its contribution to oncogenesis and determine whether its chromatin remodeling function can be specifically targeted.</p>
<h2 id="open-questions">Open Questions</h2>
<p>Despite significant advances in understanding CHRAC1 function, several important questions remain:</p>
<ol>
<li>
<p><strong>Specificity of CHRAC1 versus POLE4 interactions with POLE3:</strong> Both CHRAC1 and POLE4 form heterodimers with POLE3, but the factors determining which complex assembles in different cellular contexts are not fully understood. How is the partitioning of POLE3 between chromatin remodeling and DNA replication functions regulated?</p>
</li>
<li>
<p><strong>Direct contribution to DNA repair:</strong> While the SMARCA5-ACF1 complex is clearly implicated in DNA repair, the specific contribution of CHRAC1 to repair pathways has not been definitively established. Does CHRAC1 have distinct functions in repair versus replication-associated chromatin remodeling?</p>
</li>
<li>
<p><strong>Tissue-specific functions:</strong> Despite ubiquitous expression, CHRAC1 may have tissue-specific roles, particularly in contexts requiring intensive chromatin remodeling such as spermatogenesis. What are the consequences of CHRAC1 deficiency in specific cell types?</p>
</li>
<li>
<p><strong>Mechanistic details of YAP interaction:</strong> The recently discovered interaction between CHRAC1 and YAP in cancer contexts raises questions about whether this represents a normal physiological function or a pathological gain-of-function. Does CHRAC1 regulate Hippo pathway targets in normal cells?</p>
</li>
<li>
<p><strong>Post-translational modifications:</strong> The role of post-translational modifications of CHRAC1 in regulating its function, localization, and protein interactions remains largely unexplored.</p>
</li>
<li>
<p><strong>Relationship to other histone-fold proteins:</strong> CHRAC1 shares structural features with NF-YC and NC2alpha, which function in transcription. Whether CHRAC1 has any direct roles in transcriptional regulation beyond chromatin remodeling merits investigation.</p>
</li>
</ol>
<h2 id="references">References</h2>
<ul>
<li>
<p>[vargaweisz-1997-chrac-nature-abstract] Varga-Weisz PD, Wilm M, Bonte E, Dumas K, Mann M, Becker PB. Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II. Nature. 1997 Aug 7;388(6642):598-602. DOI: 10.1038/41587. PMID: 9252192.</p>
</li>
<li>
<p>[poot-2000-huchrac-abstract] Poot RA, Dellaire G, H√ºlsmann BB, Grimaldi MA, Corona DF, Becker PB, Bickmore WA, Varga-Weisz PD. HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins. EMBO J. 2000 Jul 3;19(13):3377-87. DOI: 10.1093/emboj/19.13.3377. PMID: 10880450.</p>
</li>
<li>
<p>[corona-2000-chrac14-16-abstract] Corona DF, Eberharter A, Budde A, Deuring R, Ferrari S, Varga-Weisz P, Wilm M, Tamkun J, Becker PB. Two histone fold proteins, CHRAC-14 and CHRAC-16, are developmentally regulated subunits of chromatin accessibility complex (CHRAC). EMBO J. 2000 Jun 15;19(12):3049-59. DOI: 10.1093/emboj/19.12.3049. PMID: 10856248.</p>
</li>
<li>
<p>[bolognese-2000-ybl1-ycl1-abstract] Bolognese F, Imbriano C, Caretti G, Mantovani R. Cloning and characterization of the histone-fold proteins YBL1 and YCL1. Nucleic Acids Res. 2000 Oct 1;28(19):3830-8. DOI: 10.1093/nar/28.19.3830. PMID: 11000277.</p>
</li>
<li>
<p>[li-2000-pole3-pole4-abstract] Li Y, Pursell ZF, Linn S. Identification and cloning of two histone fold motif-containing subunits of HeLa DNA polymerase epsilon. J Biol Chem. 2000 Jul 28;275(30):23247-52. DOI: 10.1074/jbc.M002548200. PMID: 10801849.</p>
</li>
<li>
<p>[langst-1999-nucleosome-movement-abstract] L√§ngst G, Bonte EJ, Corona DF, Becker PB. Nucleosome movement by CHRAC and ISWI without disruption or trans-displacement of the histone octamer. Cell. 1999 Jun 25;97(7):843-52. DOI: 10.1016/s0092-8674(00)80797-7. PMID: 10399913.</p>
</li>
<li>
<p>[alexiadis-1998-sv40-replication-abstract] Alexiadis V, Varga-Weisz PD, Bonte E, Becker PB, Gruss C. In vitro chromatin remodelling by chromatin accessibility complex (CHRAC) at the SV40 origin of DNA replication. EMBO J. 1998 Jun 15;17(12):3428-38. DOI: 10.1093/emboj/17.12.3428. PMID: 9628878.</p>
</li>
<li>
<p>[kukimoto-2004-chrac15-17-sliding-abstract] Kukimoto I, Elderkin S, Grimaldi M, Oelgeschl√§ger T, Varga-Weisz PD. The histone-fold protein complex CHRAC-15/17 enhances nucleosome sliding and assembly mediated by ACF. Mol Cell. 2004 Jan 30;13(2):265-77. DOI: 10.1016/s1097-2765(03)00523-9. PMID: 14759371.</p>
</li>
<li>
<p>[fyodorov-2004-acf1-chromatin-abstract] Fyodorov DV, Blower MD, Karpen GH, Kadonaga JT. Acf1 confers unique activities to ACF/CHRAC and promotes the formation rather than disruption of chromatin in vivo. Genes Dev. 2004 Jan 15;18(2):170-83. DOI: 10.1101/gad.1139604. PMID: 14752009.</p>
</li>
<li>
<p>[hartlepp-2005-structure-mechanism-abstract] Hartlepp KF, Fern√°ndez-Tornero C, Eberharter A, Gr√ºne T, M√ºller CW, Becker PB. The histone fold subunits of Drosophila CHRAC facilitate nucleosome sliding through dynamic DNA interactions. Mol Cell Biol. 2005 Nov;25(22):9886-96. DOI: 10.1128/MCB.25.22.9886-9896.2005. PMID: 16260604.</p>
</li>
<li>
<p>[gnesutta-2013-hfd-proteins-abstract] Gnesutta N, Nardini M, Mantovani R. The H2A/H2B-like histone-fold domain proteins at the crossroad between chromatin and different DNA metabolisms. Transcription. 2013 May 16;4(3):114-119. DOI: 10.4161/trns.25002. PMID: 23695160.</p>
</li>
<li>
<p>[wang-2022-chrac1-lung-cancer-abstract] Wang M, Li S, Guo W, Wang L, Huang J, Zhuo J, Lai B, Liao C, Ge T, Nie Y, Jin S, Wang M, Zhang Y, Liu Y, Li X, Zhang H. CHRAC1 promotes human lung cancer growth through regulating YAP transcriptional activity. Carcinogenesis. 2022 Apr 25;43(3):264-276. DOI: 10.1093/carcin/bgab103. PMID: 34718437.</p>
</li>
<li>
<p>[li-2024-chrac1-cancer-abstract] Li S, Wang L, Shi J, Chen Y, Xiao A, Huo B, Tian W, Zhang S, Yang G, Gong W, Zhang H. Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer. PeerJ. 2024 Jan 10;12:e16752. DOI: 10.7717/peerj.16752. PMID: 38223760.</p>
</li>
<li>
<p>[zhou-2021-iswi-cancer-review-summary] Zhou M, Yuan J, Deng Y, Fan X, Shen J. The emerging role of ISWI chromatin remodeling complexes in cancer. J Exp Clin Cancer Res. 2021 Nov 12;40(1):346. DOI: 10.1186/s13046-021-02151-x. PMID: 34772431.</p>
</li>
</ul>
<h2 id="citations">Citations</h2>
<ol>
<li>alexiadis-1998-sv40-replication-abstract.md</li>
<li>bolognese-2000-ybl1-ycl1-abstract.md</li>
<li>corona-2000-chrac14-16-abstract.md</li>
<li>fyodorov-2004-acf1-chromatin-abstract.md</li>
<li>gnesutta-2013-hfd-proteins-abstract.md</li>
<li>hartlepp-2005-structure-mechanism-abstract.md</li>
<li>kukimoto-2004-chrac15-17-sliding-abstract.md</li>
<li>langst-1999-nucleosome-movement-abstract.md</li>
<li>li-2000-pole3-pole4-abstract.md</li>
<li>li-2024-chrac1-cancer-abstract.md</li>
<li>poot-2000-huchrac-abstract.md</li>
<li>vargaweisz-1997-chrac-nature-abstract.md</li>
<li>wang-2022-chrac1-lung-cancer-abstract.md</li>
<li>zhou-2021-iswi-cancer-review-summary.md</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(CHRAC1-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9NRG0" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2025-12-26T10:33:18.903930'<br />
end_time: '2025-12-26T10:40:02.192325'<br />
duration_seconds: 403.29<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: CHRAC1<br />
  gene_symbol: CHRAC1<br />
  uniprot_accession: Q9NRG0<br />
  protein_description: 'RecName: Full=Chromatin accessibility complex protein 1; Short=CHRAC-1;<br />
    AltName: Full=Chromatin accessibility complex 15 kDa protein; Short=CHRAC-15;<br />
    Short=HuCHRAC15; AltName: Full=DNA polymerase epsilon subunit p15;'<br />
  gene_info: Name=CHRAC1; Synonyms=CHRAC15;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg.<br />
    (IPR050568); CBFD_NFYB_HMF (PF00808)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 17</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9NRG0</li>
<li><strong>Protein Description:</strong> RecName: Full=Chromatin accessibility complex protein 1; Short=CHRAC-1; AltName: Full=Chromatin accessibility complex 15 kDa protein; Short=CHRAC-15; Short=HuCHRAC15; AltName: Full=DNA polymerase epsilon subunit p15;</li>
<li><strong>Gene Information:</strong> Name=CHRAC1; Synonyms=CHRAC15;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg. (IPR050568); CBFD_NFYB_HMF (PF00808)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "CHRAC1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'CHRAC1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>CHRAC1</strong> (gene ID: CHRAC1, UniProt: Q9NRG0) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9NRG0</li>
<li><strong>Protein Description:</strong> RecName: Full=Chromatin accessibility complex protein 1; Short=CHRAC-1; AltName: Full=Chromatin accessibility complex 15 kDa protein; Short=CHRAC-15; Short=HuCHRAC15; AltName: Full=DNA polymerase epsilon subunit p15;</li>
<li><strong>Gene Information:</strong> Name=CHRAC1; Synonyms=CHRAC15;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg. (IPR050568); CBFD_NFYB_HMF (PF00808)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "CHRAC1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'CHRAC1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>CHRAC1</strong> (gene ID: CHRAC1, UniProt: Q9NRG0) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Research plan and verification<br />
- Identity check: The target is Homo sapiens CHRAC1 (UniProt Q9NRG0), also known as CHRAC-15/CHRAC15 and frequently referred to as POLE4 in the literature. It is a small histone-fold protein that forms a histone-fold heterodimer with CHRAC17/POLE3. This heterodimer functions within human CHRAC/ACF ISWI chromatin-remodeling complexes together with SMARCA5 (SNF2H) and BAZ1A (ACF1). This matches the UniProt description, organism, and domain annotations (histone fold/CBFA_NFYB family) (brown2010atpdependentchromatinremodeling pages 92-97, hartlepp2006characterisationofchrac14 pages 116-119).</p>
<p>Key concepts and definitions<br />
- CHRAC1 (CHRAC-15/POLE4): A human histone-fold protein that heterodimerizes with CHRAC17/POLE3. As a dimer, it acts as a histone analog/chaperone module in chromatin-associated complexes, particularly ISWI remodelers (CHRAC/ACF) (brown2010atpdependentchromatinremodeling pages 92-97).<br />
- Histone-fold heterodimer (POLE3‚ÄìPOLE4): A conserved H2A‚ÄìH2B‚Äìlike pair that associates with ISWI remodelers and with the DNA polymerase epsilon complex (orthology-based evidence), supporting nucleosome sliding/spacing and replication-coupled histone handling (brown2010atpdependentchromatinremodeling pages 92-97, hartlepp2006characterisationofchrac14 pages 116-119, casari2022resectionofdna pages 213-217).<br />
- CHRAC/ACF complexes: ISWI-family ATP-dependent chromatin remodeling assemblies consisting of SMARCA5 (SNF2H) and BAZ1A (ACF1); in CHRAC, the POLE3‚ÄìPOLE4 heterodimer (CHRAC17‚ÄìCHRAC15) enhances ATP-dependent nucleosome sliding activity and contributes to nucleosome spacing (brown2010atpdependentchromatinremodeling pages 92-97, borner2017rolesofnucleosome pages 22-25, jain2015effectsofnucleosome pages 95-99).<br />
- Domain context: CHRAC1 contains a histone-fold/CBFA_NFYB-like domain; partner BAZ1A contributes WAC/DDT and PHD/bromodomain modules for chromatin targeting, and the histone-fold heterodimer engages the ACF1 N-terminus (WAC motif) (hartlepp2006characterisationofchrac14 pages 116-119, borner2017rolesofnucleosome pages 22-25).</p>
<p>Recent developments and latest research (priority 2022‚Äì2024)<br />
- 2024 human ISWI interactome context: Tissue-specific interaction partners of SMARCA5 emphasize that CHRAC/ACF are major ISWI complexes mediating nucleosome spacing, with BAZ1A guiding targeting and SMARCA5 providing ATPase activity; the complex is implicated in DNA repair contexts (no CHRAC1-specific proteomics, but directly relevant complex-level updates) (Arishaka 2024; publication type: study/dissertation; URL not available) (arishaka2024identificationofnew pages 17-21).<br />
- 2022 Drosophila mechanistic links with centromere and stress: The histone-fold subunit CHRAC-14 (fly ortholog of human POLE3/POLE4 family) regulates CENP-A loading and gene expression, shows context-dependent associations with centromeric proteins and other remodelers under DNA damage, and interacts with Pol Œµ‚Äìrelated factors (Mes4), underscoring a conserved theme of CHRAC histone-fold dimers in centromere function and stress-responsive chromatin maintenance (Doppler 2022; https://doi.org/10.11588/heidok.00031436; Jan 2022) (doppler2022thehistonefold pages 20-23, doppler2022thehistonefold pages 73-75).<br />
- 2022 synthesis on DSB resection and replication chaperoning: Review synthesizes that POLE3‚ÄìPOLE4 (Dbp3/Dbp4 orthologs) serve in replication-coupled histone handling and that ISWI remodelers contribute to DSB processing, situating CHRAC1‚Äôs histone-fold dimer within DNA replication and repair pathways (Casari 2022; review; URL not available) (casari2022resectionofdna pages 213-217).</p>
<p>Molecular function and biochemical roles<br />
- Structural role: CHRAC1 functions as a histone-fold protein forming a stable heterodimer with CHRAC17/POLE3 that mimics H2A‚ÄìH2B. This dimer enhances ISWI remodeling activities, particularly nucleosome sliding by SMARCA5‚ÄìBAZ1A, and contributes to nucleosome spacing/assembly (brown2010atpdependentchromatinremodeling pages 92-97, borner2017rolesofnucleosome pages 22-25, jain2015effectsofnucleosome pages 95-99).<br />
- Interaction with remodelers: The heterodimer engages ACF1‚Äôs N-terminus (WAC motif), supporting assembly and function of ACF/CHRAC complexes (hartlepp2006characterisationofchrac14 pages 116-119).<br />
- Replication-associated chaperone function: Orthology-informed and review-based evidence indicates that the POLE3‚ÄìPOLE4 pair acts as a histone chaperone at replication forks for parental histone (H3‚ÄìH4) redeposition; Drosophila and yeast lines of evidence place the histone-fold pair at the replication-coupled chromatin interface (casari2022resectionofdna pages 213-217, borner2017rolesofnucleosome pages 22-25).</p>
<p>Subcellular localization<br />
- Nuclear: The CHRAC15/CHRAC17 (POLE4/POLE3) histone-fold dimer is imported to the nucleus as a heterodimer; ACF1/SNF2H accumulate at pericentric heterochromatin in late S-phase in referenced cell studies, consistent with nuclear chromatin roles (Brown 2010) (brown2010atpdependentchromatinremodeling pages 92-97).</p>
<p>Biological processes and pathways<br />
- Chromatin remodeling and organization: CHRAC/ACF remodelers slide and space nucleosomes to promote chromatin assembly and establish a repressive ground state of chromatin; the CHRAC1-containing histone-fold dimer enhances these activities (borner2017rolesofnucleosome pages 22-25, jain2015effectsofnucleosome pages 95-99).<br />
- DNA replication: The POLE3‚ÄìPOLE4 histone-fold chaperone pair supports replication-coupled parental histone handling and chromatin integrity; in human cells, CHRAC1 (POLE4) is the CHRAC component of this conserved module (casari2022resectionofdna pages 213-217, brown2010atpdependentchromatinremodeling pages 92-97).<br />
- DNA damage response and repair: Evidence from Drosophila shows CHRAC histone-fold subunits contribute to DNA damage checkpoint integrity and repair efficiency; broader reviews link ISWI remodelers to DSB resection and processing, situating CHRAC1 at the interface of chromatin remodeling and repair (doppler2022thehistonefold pages 20-23, casari2022resectionofdna pages 213-217).<br />
- Centromere/kinetochore regulation: Drosophila data indicate CHRAC-14 limits aberrant CENP-A loading and engages centromeric interactors; this suggests conserved centromeric chromatin maintenance roles for the histone-fold dimer family (doppler2022thehistonefold pages 20-23, doppler2022thehistonefold pages 73-75).</p>
<p>Current applications and real-world implementations<br />
- Functional genomics and proteomics: Co-immunoprecipitation/mass spectrometry approaches identify CHRAC/ACF complex constituents and replication-linked associates (e.g., RFC subunits, Cdc6) in vivo, informing network models of replication-coupled chromatin maintenance where CHRAC1 participates (Jain 2015; https://doi.org/10.5282/edoc.19018; Jan 2015) (jain2015effectsofnucleosome pages 95-99).<br />
- Chromatin and replication stress models: Cellular studies tracking ISWI/ACF1 localization during S phase and heterochromatin replication, and fly models of DNA damage/centromere regulation, are used to infer conserved roles of human CHRAC1 in chromatin robustness under replication stress (brown2010atpdependentchromatinremodeling pages 92-97, doppler2022thehistonefold pages 20-23).</p>
<p>Expert opinions and authoritative synthesis<br />
- Mechanistic reviews emphasize that ISWI remodelers (including CHRAC/ACF) function in nucleosome spacing and repressive chromatin, and that POLE3‚ÄìPOLE4 serves a replication-coupled histone chaperone role; these syntheses provide consensus for CHRAC1‚Äôs placement in chromatin remodeling‚Äìreplication interfaces (casari2022resectionofdna pages 213-217, borner2017rolesofnucleosome pages 22-25).</p>
<p>Relevant statistics and data points<br />
- Nuclear import: CHRAC15‚ÄìCHRAC17 imported as a heterodimer; ACF1/SNF2H colocalization at pericentric heterochromatin in late S phase (cell-based observations summarized in Brown 2010) (brown2010atpdependentchromatinremodeling pages 92-97).<br />
- DNA damage phenotypes (fly): Depletion of CHRAC-14 causes hypersensitivity to genotoxic stress, failure of G2/M checkpoint, accumulation of Œ≥H2Av, and comet assay DNA damage, suggesting a conserved role in the DNA damage response; while quantitative values are not provided in the excerpt, the directionality is consistent and supported (Doppler 2022; Jan 2022) (doppler2022thehistonefold pages 20-23).</p>
<p>Open questions and limitations<br />
- Direct, recent (2023‚Äì2024) human CHRAC1-specific mechanistic papers are limited in the present evidence set. Current understanding extrapolates from conserved complex biology, Drosophila/yeast orthologs, and reviews. Targeted human CHRAC1 studies defining its unique contributions beyond the POLE3‚ÄìPOLE4 dimer function remain an active area.</p>
<p>Source summary with URLs and dates<br />
- Brown 2010. Atp-dependent chromatin remodeling complexes in Xenopus development. Summary includes human CHRAC composition and nuclear import; URL not available in excerpt (brown2010atpdependentchromatinremodeling pages 92-97).<br />
- Doppler 2022. The histone fold protein CHRAC-14 controls CENP-A loading and gene expression in Drosophila melanogaster. Jan 2022. https://doi.org/10.11588/heidok.00031436 (doppler2022thehistonefold pages 20-23, doppler2022thehistonefold pages 73-75).<br />
- Hartlepp 2006. Characterisation of CHRAC14 and CHRAC16‚Ä¶ Jan 2006. https://doi.org/10.5282/edoc.5149 (hartlepp2006characterisationofchrac14 pages 116-119).<br />
- B√∂rner 2017. Roles of nucleosome remodeling factors ACF1 and Domino during Drosophila melanogaster oogenesis. Jan 2017. https://doi.org/10.5282/edoc.20348 (borner2017rolesofnucleosome pages 22-25).<br />
- Jain 2015. Effects of nucleosome remodeling factor ACF1 on in vivo chromatin organization. Jan 2015. https://doi.org/10.5282/edoc.19018 (jain2015effectsofnucleosome pages 95-99).<br />
- Casari 2022. Resection of DNA double-strand breaks: novel regulatory mechanisms by checkpoint proteins and chromatin remodelers. 2022. URL not available in excerpt (casari2022resectionofdna pages 213-217).<br />
- Arishaka 2024. Identification of new tissue-specific interaction partners of chromatin remodelling ATPase Smarca5. 2024. URL not available in excerpt (arishaka2024identificationofnew pages 17-21).</p>
<p>Embedded evidence table<br />
| Reference (first author, year) | Focus / Model | What it shows about CHRAC1/POLE4 or CHRAC complexes (one-sentence) | Key partners / complexes mentioned | URL (DOI or link) | Publication date (month/year) |<br />
|---|---|---|---|---:|---:|<br />
| Brown 2010 (brown2010atpdependentchromatinremodeling pages 92-97) | Review / Xenopus / comparative (human context discussed) | Describes CHRAC15/POLE4 as a histone-fold subunit of human HuCHRAC that forms a heterodimer with CHRAC17/POLE3, enhancing ISWI (ACF/SNF2H) nucleosome-sliding activity and imported to the nucleus as a dimer. | SNF2H (SMARCA5), ACF1 (BAZ1A), CHRAC17 (POLE3) | N/A | 2010 |<br />
| Doppler 2022 (doppler2022thehistonefold pages 20-23) | Experimental thesis / Drosophila | Shows histone-fold CHRAC subunits (CHRAC-14) heterodimerize (with CHRAC-16), control CENP-A loading, influence gene expression, and connect to Pol Œµ-related factors under stress. | CHRAC-16, Mes4 (Pol Œµ link), CENP-A, ATRX, pBAF | https://doi.org/10.11588/heidok.00031436 | Jan/2022 |<br />
| Doppler 2022 (doppler2022thehistonefold pages 73-75) | Experimental thesis / Drosophila (additional data) | Provides mass-spec evidence of context-dependent associations of CHRAC histone-fold subunits with centromeric proteins and other remodelers, and notes detection/antibody challenges. | CENP-A, DEK, XNP/ATRX, pBAF | https://doi.org/10.11588/heidok.00031436 | Jan/2022 |<br />
| Arishaka 2024 (arishaka2024identificationofnew pages 17-21) | Proteomics / human tissues (SMARCA5 interactome) | Identifies tissue-specific interaction partners of SMARCA5 and emphasizes ISWI complexes (including CHRAC/ACF) in nucleosome spacing, chromatin targeting and DNA repair. | SMARCA5 (ISWI), BAZ1A (ACF1), other ISWI partners | N/A | 2024 |<br />
| Casari 2022 (casari2022resectionofdna pages 213-217) | Review / mechanistic (multi-organism synthesis) | Summarizes conservation of CHRAC-family histone-fold subunits and links POLE3‚ÄìPOLE4 (Dbp3/Dbp4 orthologs) to roles in replication-coupled histone handling and DSB processing via remodeler interplay. | POLE3, POLE4, ISWI family remodelers | N/A | 2022 |<br />
| Hartlepp 2006 (hartlepp2006characterisationofchrac14 pages 116-119) | Dissertation / molecular characterization (Drosophila focus) | Characterises CHRAC histone-fold subunits, reports structural/functional similarity between CHRAC and Pol Œµ histone-fold dimers, and shows interaction with ACF1 N-terminal WAC motif. | ACF1 (WAC motif), CHRAC16, Pol Œµ (shared subunit context) | https://doi.org/10.5282/edoc.5149 | Jan/2006 |<br />
| B√∂rner 2017 (borner2017rolesofnucleosome pages 22-25) | Dissertation / Drosophila oogenesis | Demonstrates ACF/CHRAC (ISWI complexes) use small histone-fold proteins as DNA chaperones for nucleosome sliding/spacing and parental histone redeposition, implicating roles at replication and chromatin assembly. | ACF1, ISWI, NAP-1 (cooperation in assembly) | https://doi.org/10.5282/edoc.20348 | Jan/2017 |<br />
| Jain 2015 (jain2015effectsofnucleosome pages 95-99) | Proteomics / Drosophila in vivo studies | Proteomics shows stable ACF1 association with small CHRAC subunits and recovery of replication-associated proteins (RFCs, Cdc6), supporting functional links between CHRAC/ACF and replication-linked chromatin organization. | ACF1, ISWI, RFC3/RFC4, Cdc6 | https://doi.org/10.5282/edoc.19018 | Jan/2015 |</p>
<p><em>Table: Concise, sourced summary of key experimental and review evidence (2006‚Äì2024) describing CHRAC1/CHRAC‚Äë15 (POLE4) identity, conserved histone‚Äëfold heterodimerization, complex memberships, and roles in nucleosome sliding, replication‚Äëlinked histone handling and DNA repair (context IDs cited).</em></p>
<p>Conclusions<br />
- CHRAC1 is the human histone-fold protein CHRAC-15/POLE4 that dimerizes with CHRAC17/POLE3, integrates into CHRAC/ACF ISWI chromatin remodeling complexes with SMARCA5 and BAZ1A, and localizes to the nucleus. This histone-fold dimer enhances nucleosome sliding/spacing, supports replication-coupled parental histone redeposition, and participates in chromatin maintenance under DNA damage and at centromeric chromatin. Current 2022‚Äì2024 sources reinforce these roles at the complex level and via orthology, while direct 2023‚Äì2024 human CHRAC1-specific mechanistic insights remain comparatively scarce and warrant further targeted investigation (brown2010atpdependentchromatinremodeling pages 92-97, doppler2022thehistonefold pages 20-23, hartlepp2006characterisationofchrac14 pages 116-119, borner2017rolesofnucleosome pages 22-25, jain2015effectsofnucleosome pages 95-99, casari2022resectionofdna pages 213-217, arishaka2024identificationofnew pages 17-21).</p>
<p>References</p>
<ol>
<li>
<p>(brown2010atpdependentchromatinremodeling pages 92-97): EE Brown. Atp-dependent chromatin remodeling complexes in xenopus development. Unknown journal, 2010.</p>
</li>
<li>
<p>(hartlepp2006characterisationofchrac14 pages 116-119): Klaus F. Hartlepp. Characterisation of chrac14 and chrac16, the two histone fold subunits of the chromatin accessibility complex. Dissertation, Jan 2006. URL: https://doi.org/10.5282/edoc.5149, doi:10.5282/edoc.5149. This article has 0 citations.</p>
</li>
<li>
<p>(casari2022resectionofdna pages 213-217): E Casari. Resection of dna double-strand breaks: novel regulatory mechanisms by checkpoint proteins and chromatin remodelers. Unknown journal, 2022.</p>
</li>
<li>
<p>(borner2017rolesofnucleosome pages 22-25): Kenneth B√∂rner. Roles of nucleosome remodeling factors acf1 and domino during drosophila melanogaster oogenesis. Dissertation, Jan 2017. URL: https://doi.org/10.5282/edoc.20348, doi:10.5282/edoc.20348. This article has 0 citations.</p>
</li>
<li>
<p>(jain2015effectsofnucleosome pages 95-99): Dhawal Jain. Effects of nucleosome remodeling factor acf1 on in vivo chromatin organization. Dissertation, Jan 2015. URL: https://doi.org/10.5282/edoc.19018, doi:10.5282/edoc.19018. This article has 1 citations.</p>
</li>
<li>
<p>(arishaka2024identificationofnew pages 17-21): Y Arishaka. Identification of new tissue-specific interaction partners of chromatin remodelling atpase smarca5. Unknown journal, 2024.</p>
</li>
<li>
<p>(doppler2022thehistonefold pages 20-23): Sarah Doppler. The histone fold protein chrac-14 controls cenp-a loading and gene expression in drosophila melanogaster. Text, Jan 2022. URL: https://doi.org/10.11588/heidok.00031436, doi:10.11588/heidok.00031436. This article has 0 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(doppler2022thehistonefold pages 73-75): Sarah Doppler. The histone fold protein chrac-14 controls cenp-a loading and gene expression in drosophila melanogaster. Text, Jan 2022. URL: https://doi.org/10.11588/heidok.00031436, doi:10.11588/heidok.00031436. This article has 0 citations and is from a peer-reviewed journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>brown2010atpdependentchromatinremodeling pages 92-97</li>
<li>arishaka2024identificationofnew pages 17-21</li>
<li>casari2022resectionofdna pages 213-217</li>
<li>jain2015effectsofnucleosome pages 95-99</li>
<li>doppler2022thehistonefold pages 20-23</li>
<li>borner2017rolesofnucleosome pages 22-25</li>
<li>doppler2022thehistonefold pages 73-75</li>
<li>https://doi.org/10.11588/heidok.00031436;</li>
<li>https://doi.org/10.5282/edoc.19018;</li>
<li>https://doi.org/10.11588/heidok.00031436</li>
<li>https://doi.org/10.5282/edoc.5149</li>
<li>https://doi.org/10.5282/edoc.20348</li>
<li>https://doi.org/10.5282/edoc.19018</li>
<li>https://doi.org/10.5282/edoc.5149,</li>
<li>https://doi.org/10.5282/edoc.20348,</li>
<li>https://doi.org/10.5282/edoc.19018,</li>
<li>https://doi.org/10.11588/heidok.00031436,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(CHRAC1-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9NRG0" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: true<br />
start_time: '2025-11-04T03:14:15.858739'<br />
end_time: '2025-11-04T03:14:15.859762'<br />
duration_seconds: 0.0<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: Q9NRG0<br />
  gene_symbol: CHRAC1<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 113</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<p>Please provide a comprehensive research report on the gene CHRAC1 (Q9NRG0) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function. </p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="chrac1-q9nrg0-chromatin-accessibility-complex-subunit-1-in-human">CHRAC1 (Q9NRG0) ‚Äì Chromatin Accessibility Complex Subunit 1 in Human</h1>
<h2 id="overview-and-key-concepts">Overview and Key Concepts</h2>
<p><strong>CHRAC1</strong> (Chromatin Accessibility Complex subunit 1, also known as CHRAC15 or YCL1) is a small (~15 kDa, 131 amino acids) protein that plays a structural role in chromatin remodeling and DNA replication. It was first identified as part of the <strong>CHRomatin Accessibility Complex (CHRAC)</strong>, an ATP-dependent chromatin-remodeling complex originally discovered in <em>Drosophila</em> and later in mammals (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Chromatin%20remodeling%20complexes%20containing%20the,complexes%20via%20association%20with%20different">jeccr.biomedcentral.com</a>). CHRAC1 contains a <strong>histone-fold motif</strong>, a structural domain through which it heterodimerizes with another histone-fold protein, typically <strong>POLE3</strong> (also called CHRAC17) (<a href="https://thebiogrid.org/114419/publication/the-histone-fold-protein-complex-chrac-1517-enhances-nucleosome-sliding-and-assembly-mediated-by-acf.html#:~:text=Read%20More">thebiogrid.org</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>). This CHRAC1‚ÄìPOLE3 pair is analogous to histone H2A‚ÄìH2B dimers in structure (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=,DNA%20Interaction">pmc.ncbi.nlm.nih.gov</a>) and is a non-enzymatic <strong>accessory module</strong> within larger complexes. The CHRAC1/POLE3 heterodimer does not itself catalyze reactions, but it <strong>binds DNA and histones</strong> and is essential for the activity of the complexes it belongs to (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/30217558/#:~:text=Maintenance%20of%20epigenetic%20integrity%20relies,to%20selectively%20bind%20to%20histones">pubmed.ncbi.nlm.nih.gov</a>). </p>
<p>CHRAC1 is encoded on chromosome 8 (8q24.3) and is expressed in the nucleus in most human cells. It is predicted to be intracellular and indeed localizes to the <strong>nucleoplasm</strong> (chromatin-rich nuclear space) (<a href="https://www.proteinatlas.org/ENSG00000104472-CHRAC1#:~:text=Subcellular%20location,i%7D%20Low%20tissue%20specificity">www.proteinatlas.org</a>). Consistent with a fundamental role in genome maintenance, CHRAC1 shows <strong>low tissue specificity</strong>, meaning it is expressed across a wide range of cell types (<a href="https://www.proteinatlas.org/ENSG00000104472-CHRAC1#:~:text=Subcellular%20location,i%7D%20Low%20tissue%20specificity">www.proteinatlas.org</a>). In summary, CHRAC1 is a conserved chromatin-associated protein that serves as a structural subunit in critical nuclear complexes for DNA packaging and replication.</p>
<h2 id="molecular-function-and-structure">Molecular Function and Structure</h2>
<p><strong>Histone-Fold Protein and Heterodimer Formation:</strong> CHRAC1 belongs to a family of small histone-fold proteins that function in pairs. It forms a tight heterodimer with POLE3 (also known as CHRAC17), another histone-fold protein (<a href="https://thebiogrid.org/114419/publication/the-histone-fold-protein-complex-chrac-1517-enhances-nucleosome-sliding-and-assembly-mediated-by-acf.html#:~:text=%5BACF%5D%29%20associates%20with%20histone,17%20interacts%20with%20another">thebiogrid.org</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>). This dimer resembles the histone H2A‚ÄìH2B dimer in both structure and DNA-binding mode (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=,DNA%20Interaction">pmc.ncbi.nlm.nih.gov</a>). Structural modeling and alignments have shown that the Drosophila CHRAC-14/16 heterodimer (homologous to human CHRAC1/POLE3) superimposes onto an H2A‚ÄìH2B dimer bound to DNA (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=,DNA%20Interaction">pmc.ncbi.nlm.nih.gov</a>), highlighting the evolutionary repurposing of histone-like modules in chromatin machinery. The CHRAC1‚ÄìPOLE3 dimer has a positively charged surface that can bind directly to <strong>double-stranded DNA</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to">pmc.ncbi.nlm.nih.gov</a>). This DNA-binding ability is unique among subunits of replicative polymerases and remodelers ‚Äì in fact, inclusion of the histone-fold pair allows the holoenzymes containing CHRAC1 to grip nucleic acids more stably (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to">pmc.ncbi.nlm.nih.gov</a>). Both yeast and human studies have demonstrated that these subunits also associate with core histones: for example, the yeast homolog (Dpb4) can be chemically crosslinked to histone proteins on DNA (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L922%20propagate%20a,%CE%B5%20through%20Dpb4%2C%20with%20a">pmc.ncbi.nlm.nih.gov</a>). This suggests the heterodimer can <strong>bridge DNA and nucleosomes</strong>, stabilizing protein‚ÄìDNA interactions during chromatin remodeling and replication.</p>
<p><strong>Association with Complexes:</strong> CHRAC1‚Äôs primary function is as a <strong>non-catalytic subunit of larger chromatin-associated complexes</strong>. It is a dedicated component of the CHRAC/ACF family of ISWI-type chromatin remodelers. In humans, the canonical <strong>ACF (ATP-utilizing Chromatin Assembly and Remodeling Factor)</strong> complex consists of the SNF2H ATPase (SMARCA5) and the large accessory subunit ACF1 (BAZ1A) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=BAZ1A%20forms%20ACF%20complexes%20together,the%20ACF%20complex%2C%20BAZ1A%20stimulates">jeccr.biomedcentral.com</a>). When CHRAC1 and POLE3 are incorporated, this forms the four-subunit <strong>CHRAC complex</strong> (consisting of SMARCA5, BAZ1A, CHRAC1, and POLE3) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=%28SMARCA1%2F5%20and%20RSF1%29%2C%20ACF,5%20%28SMARCA1%2F5%2C%20BAZ2B">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>). CHRAC1 directly interacts with ACF1 (BAZ1A) via its histone-fold partner, and this interaction is <strong>essential for the remodeler‚Äôs function</strong> (<a href="https://thebiogrid.org/114419/publication/the-histone-fold-protein-complex-chrac-1517-enhances-nucleosome-sliding-and-assembly-mediated-by-acf.html#:~:text=%5BACF%5D%29%20associates%20with%20histone,17%20interacts%20with%20another">thebiogrid.org</a>). Notably, CHRAC1 is historically referred to as <strong>‚Äúp15‚Äù</strong>, and POLE3 as ‚Äúp17,‚Äù reflecting their molecular weights (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=remodeling%20complexes%20came%20with%20the,of%20human%20Pol%20%CE%B5%2C%20p12">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to">pmc.ncbi.nlm.nih.gov</a>). These two subunits form a stable sub-complex that can attach to different machines: they are part of CHRAC, and intriguingly, one of them (POLE3/p17) is also a subunit of the DNA polymerase Œµ complex (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=subunits%2C%20called%20p15%20and%20p17,of%20human%20Pol%20%CE%B5%2C%20p12">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=homology%20to%20the%20unique%20HFM,the%20two%20complexes%2C%20but%20this">pmc.ncbi.nlm.nih.gov</a>). <strong>Polymerase Œµ (Pol Œµ)</strong>, the leading-strand DNA polymerase in replication, has four subunits; two are large enzymatic subunits, and two are small histone-fold subunits (POLE3 and POLE4, historically p17 and p12) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=remodeling%20complexes%20came%20with%20the,of%20human%20Pol%20%CE%B5%2C%20p12">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=purified%20CHRAC%20in%20multiple%20species,that%20the%20human%20p12%2Fp17%20heterodimer">pmc.ncbi.nlm.nih.gov</a>). Importantly, the <strong>p17/CHRAC17 subunit is shared</strong> between Pol Œµ and CHRAC in mammals (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=remodeling%20complexes%20came%20with%20the,of%20human%20Pol%20%CE%B5%2C%20p12">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=homology%20to%20the%20unique%20HFM,the%20two%20complexes%2C%20but%20this">pmc.ncbi.nlm.nih.gov</a>), whereas CHRAC1 (p15) is unique to the chromatin remodeling complex. This shared subunit reflects a conserved theme: in yeast, the Pol Œµ accessory subunit Dpb4 is also part of an ISWI remodeling complex (yeast Isw2 complex) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=together%20with%20Ioc2%20and%20Ioc4,activation%20until%20signal%20thresholds%20are">jeccr.biomedcentral.com</a>). The presence of common subunits suggests functional coupling between replication and chromatin remodeling machineries.</p>
<p><strong>Biochemical Activity:</strong> Although CHRAC1 itself has no enzymatic activity (it does not hydrolyze ATP or modify substrates), it is <strong>critical for the activity of its host complexes</strong>. In the context of ACF/CHRAC, CHRAC1‚ÄìPOLE3 acts as a modulatory module that <strong>enhances nucleosome remodeling</strong>. A key study in <em>Molecular Cell (2004)</em> demonstrated that adding the CHRAC1/POLE3 (p15/p17) pair to the ACF complex greatly <strong>facilitates nucleosome sliding and assembly</strong> on DNA (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Furthermore%2C%20CHRAC1%20and%20POLE3%20interaction,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>). In this study, the reconstituted human CHRAC complex showed more efficient ATP-dependent repositioning of nucleosomes than the two-subunit ACF core alone, indicating that CHRAC1 and its partner improve the remodeler‚Äôs ability to <strong>mobilize histone octamers</strong> (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Furthermore%2C%20CHRAC1%20and%20POLE3%20interaction,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>). The CHRAC1‚ÄìPOLE3 heterodimer is thought to nucleate contacts with the nucleosomal DNA or histones, aiding the SNF2H motor in <strong>gripping and moving nucleosomes</strong> (<a href="https://thebiogrid.org/114419/publication/the-histone-fold-protein-complex-chrac-1517-enhances-nucleosome-sliding-and-assembly-mediated-by-acf.html#:~:text=%5BACF%5D%29%20associates%20with%20histone,17%20interacts%20with%20another">thebiogrid.org</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>). Direct interaction of the CHRAC1/POLE3 module with the ACF1 subunit is required for this stimulatory effect (<a href="https://thebiogrid.org/114419/publication/the-histone-fold-protein-complex-chrac-1517-enhances-nucleosome-sliding-and-assembly-mediated-by-acf.html#:~:text=%5BACF%5D%29%20associates%20with%20histone,17%20interacts%20with%20another">thebiogrid.org</a>), suggesting CHRAC1 acts as an adapter linking the ATPase complex to the nucleosome substrate.</p>
<p>Within the Pol Œµ holoenzyme, the analogous histone-fold pair (POLE3‚ÄìPOLE4) performs a different but related role. It has been shown to function as a <strong>histone chaperone</strong> ‚Äì specifically binding histones H3‚ÄìH4 and facilitating their proper assembly behind the replication fork (<a href="https://pubmed.ncbi.nlm.nih.gov/30217558/#:~:text=Maintenance%20of%20epigenetic%20integrity%20relies,to%20selectively%20bind%20to%20histones">pubmed.ncbi.nlm.nih.gov</a>). In a 2018 biochemical study, the POLE3/POLE4 subcomplex of Pol Œµ was found to selectively bind H3‚ÄìH4 and promote <strong>replication-coupled nucleosome assembly</strong>, thereby maintaining chromatin integrity during DNA synthesis (<a href="https://pubmed.ncbi.nlm.nih.gov/30217558/#:~:text=Maintenance%20of%20epigenetic%20integrity%20relies,to%20selectively%20bind%20to%20histones">pubmed.ncbi.nlm.nih.gov</a>). By analogy, the CHRAC1‚ÄìPOLE3 dimer (which shares the POLE3 component) likely has a similar affinity for histones or DNA. In Pol Œµ, these small subunits also confer high affinity for double-stranded DNA, making Pol Œµ unique among DNA polymerases in its ability to <strong>stay attached to dsDNA without external clamps</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to">pmc.ncbi.nlm.nih.gov</a>). This property is crucial for <strong>holding and organizing DNA</strong> as the polymerase synthesizes the new strand. While CHRAC1 is not part of Pol Œµ, the shared architecture implies that CHRAC1‚Äôs presence in the CHRAC complex equips the chromatin remodeler with a DNA/histone-binding module analogous to Pol Œµ‚Äôs, reinforcing the idea that CHRAC1‚Äôs primary function is <strong>structural tethering</strong>: it helps position and stabilize the larger enzymatic subunits on chromatin substrates.</p>
<h2 id="biological-processes-and-pathways">Biological Processes and Pathways</h2>
<p><strong>Chromatin Remodeling and Nucleosome Positioning:</strong> The defining role of CHRAC1 is in <strong>chromatin remodeling</strong>. CHRAC1-containing complexes (ACF/CHRAC) use the energy of ATP (via the ISWI ATPase SNF2H) to reposition nucleosomes along DNA. CHRAC was originally purified (in <em>Drosophila</em>) by its ability to <strong>increase chromatin accessibility</strong> ‚Äì chromatin reconstituted with CHRAC was more easily cut by restriction enzymes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L879%20CHRAC%20was,disorganized%20nucleosomes%20formed%20in%20the">pmc.ncbi.nlm.nih.gov</a>). This activity reflects the complex‚Äôs ability to slide nucleosomes and expose DNA regions. In addition, CHRAC can drive the formation of <strong>regularly spaced nucleosome arrays</strong> in vitro, organizing chromatin structure (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=CHRAC%20was%20initially%20purified%20from,disorganized%20nucleosomes%20formed%20in%20the">pmc.ncbi.nlm.nih.gov</a>). In general, <strong>ACF and CHRAC function as nucleosome spacing factors</strong>, converting irregular nucleosome distributions into evenly spaced, higher-order chromatin ‚Äì a process often associated with repressive chromatin formation (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Chromatin%20remodeling%20complexes%20containing%20the,complexes%20via%20association%20with%20different">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=BAZ1A%20forms%20ACF%20complexes%20together,the%20ACF%20complex%2C%20BAZ1A%20stimulates">jeccr.biomedcentral.com</a>). CHRAC1 is an essential part of this process: when CHRAC1/POLE3 are bound to ACF, the complex is optimized for <strong>sliding nucleosomes along DNA and assembling histones onto DNA</strong> in an orderly manner (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Furthermore%2C%20CHRAC1%20and%20POLE3%20interaction,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>). This is corroborated by experiments showing that <strong>removing or mutating the CHRAC1‚ÄìPOLE3 subunits impairs ATP-dependent nucleosome mobilization</strong> by ACF (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>). Thus, CHRAC1‚Äôs broader structural role is to ensure chromatin remodelers can effectively <strong>reposition nucleosomes</strong>, which impacts DNA accessibility for transcription, replication, and repair.</p>
<p>Because of this role, CHRAC1 influences <strong>transcriptional regulation</strong> indirectly. By helping position nucleosomes, CHRAC1-containing complexes can either <strong>repress or activate gene expression</strong> depending on context. For instance, well-spaced nucleosome arrays formed by ACF/CHRAC are often linked to transcriptional repression (stabilizing a more condensed chromatin state) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Chromatin%20remodeling%20complexes%20containing%20the,complexes%20via%20association%20with%20different">jeccr.biomedcentral.com</a>). However, chromatin remodelers can also enable transcription by clearing or sliding nucleosomes at promoters. A recent study provides a concrete example: <strong>CHRAC1 was found to interact with the transcriptional co-activator YAP (Yes-associated protein)</strong> and promote YAP-driven gene expression in cancer cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=Hippo%20pathway%2C%20thereby%20promoting%20tumorigenesis,YAP%20in%20breast%20and%20cervical">pmc.ncbi.nlm.nih.gov</a>). In this 2024 study (PeerJ, Jan 10 2024), Li <em>et al.</em> showed that CHRAC1 physically associates with YAP and is required for efficient transcription of YAP target oncogenes in breast and cervical cancer cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=match%20at%20L53%20Hippo%20pathway%2C,YAP%20in%20breast%20and%20cervical">pmc.ncbi.nlm.nih.gov</a>). CHRAC1 depletion led to reduced YAP target gene expression, suggesting that CHRAC1‚Äôs chromatin-remodeling function may facilitate <strong>opening of chromatin at YAP-regulated loci</strong> to enhance transcription (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=Hippo%20pathway%2C%20thereby%20promoting%20tumorigenesis,YAP%20in%20breast%20and%20cervical">pmc.ncbi.nlm.nih.gov</a>). This illustrates how CHRAC1, through the CHRAC complex, can participate in specific gene regulatory programs ‚Äì not by sequence-specific DNA binding, but by <strong>modulating nucleosome positioning</strong> at the behest of other DNA-binding factors.</p>
<p><strong>DNA Replication and Epigenetic Maintenance:</strong> CHRAC1 is also important in the context of DNA replication. While it is not a core component of the replication fork machinery, its relationships to Pol Œµ and chromatin assembly tie it closely to replication processes. The <strong>leading-strand DNA polymerase Œµ</strong>, which synthesizes new DNA during S-phase, contains a histone-fold subcomplex (POLE3‚ÄìPOLE4) related to CHRAC1‚ÄìPOLE3. This subcomplex chaperones histones and helps re-deposit them onto newly replicated DNA (<a href="https://pubmed.ncbi.nlm.nih.gov/30217558/#:~:text=Maintenance%20of%20epigenetic%20integrity%20relies,to%20selectively%20bind%20to%20histones">pubmed.ncbi.nlm.nih.gov</a>). Because POLE3 is common to both Pol Œµ and CHRAC, there appears to be a division of labor: <strong>Pol Œµ (with POLE3‚ÄìPOLE4) handles immediate nucleosome reassembly</strong>, while <strong>CHRAC (with CHRAC1‚ÄìPOLE3) may assist in specialized contexts of replication</strong>, such as heterochromatin. Indeed, evidence suggests CHRAC is recruited during replication of heterochromatic regions to ensure proper chromatin is reformed. Two core components of CHRAC (SNF2H and ACF1) have been observed to <strong>colocalize with heterochromatin protein HP1Œ≤ and with BrdU (newly synthesized DNA) during late S phase</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=Evidence%20from%20metazoan%20cells%20indicates,and%20BrdU%2C%20during%20S%20phase">pmc.ncbi.nlm.nih.gov</a>). Late S-phase is when pericentromeric <strong>heterochromatin</strong> is replicated, and this colocalization indicates CHRAC is present at replication sites of silent repetitive DNA. Researchers propose that the shared POLE3/p17 subunit might serve as a molecular link, targeting both Pol Œµ and CHRAC to replicating heterochromatic regions (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=has%20been%20found%20in%20a,during%20which%20time%20heterochromatin%20is">pmc.ncbi.nlm.nih.gov</a>). In this model, Pol Œµ synthesizes DNA while CHRAC remodels nucleosomes in tandem, thereby <strong>maintaining the epigenetic state</strong> (silenced or open) of the DNA after replication (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=propagate%20a%20silenced%20state%2C%20or,%CE%B5%20through%20Dpb4%2C%20with%20a">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=has%20been%20found%20in%20a,during%20which%20time%20heterochromatin%20is">pmc.ncbi.nlm.nih.gov</a>). Experimental support comes from yeast: disruption of Dpb4 (the yeast POLE3 homolog shared with yeast CHRAC) causes defects in inheriting silent chromatin at telomeres, showing equal parts loss and gain of silencing (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=this%20region%20in%20opposition%20to,silencing%20and%20activation%20in%20this">pmc.ncbi.nlm.nih.gov</a>). Similarly, in human cells, <strong>Pol Œµ and CHRAC cooperate to replicate through dense chromatin</strong> ‚Äì Pol Œµ‚Äôs small subunits and CHRAC can both bind histones/DNA, helping to <strong>propagate chromatin structure</strong> onto daughter strands (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L922%20propagate%20a,%CE%B5%20through%20Dpb4%2C%20with%20a">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=propagate%20a%20silenced%20state%2C%20or,%CE%B5%20through%20Dpb4%2C%20with%20a">pmc.ncbi.nlm.nih.gov</a>). Moreover, cell-free replication assays have demonstrated a direct role for CHRAC in assisting DNA synthesis through chromatin: for example, adding purified human CHRAC to an <em>in vitro</em> replication system allowed more efficient duplication of nucleosomal DNA by <strong>repositioning nucleosomes at a replication origin</strong> that would otherwise block replication initiation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=CHRAC%20may%20also%20contribute%2C%20directly,to%20rearrange%20the%20nucleosomes%20on">pmc.ncbi.nlm.nih.gov</a>). This indicates CHRAC1‚Äôs complex actively helps <strong>overcome nucleosomal barriers during replication</strong>, ensuring that DNA replication progresses and that nucleosomes are properly reassembled afterward.</p>
<p><strong>DNA Repair and Other Pathways:</strong> There is also evidence implicating CHRAC1-containing complexes in DNA damage responses. The ACF1‚ÄìSNF2H remodeler (with which CHRAC1 associates in CHRAC) is known to be recruited to DNA double-strand breaks and contribute to repair. BAZ1A (ACF1) and SNF2H help load repair factors at breaks and promote non-homologous end joining, and loss of either makes cells hypersensitive to DNA damage (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=In%20normal%20cells%2C%20BAZ1A%20is,strand%20breaks%20%28DSBs%29%20and%20DSB">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=the%20KU70%2F80%20complex%20and%20formation,disruption%20of%20the%20ACF%20complex">jeccr.biomedcentral.com</a>). CHRAC1 has not been singled out in these studies, but as part of the same complex it likely participates in <strong>chromatin relaxation around DNA breaks</strong>, facilitating repair factor access. Additionally, CHRAC1‚Äôs partner POLE3 has been linked to stabilizing replication forks under stress ‚Äì recent work showed that loss of POLE3/POLE4 leads to replication gaps and hypersensitivity to PARP inhibitors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11229324/#:~:text=The%20loss%20of%20DNA%20polymerase,the%20levels%20of%20POLE3%2C%20POLE4">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11229324/#:~:text=Figure%201,the%20levels%20of%20POLE3%2C%20POLE4">pmc.ncbi.nlm.nih.gov</a>). While these studies focused on Pol Œµ‚Äôs subunits, they underscore the importance of the histone-fold modules in maintaining genome stability. By extension, CHRAC1 (through CHRAC) contributes to safeguarding genome integrity during both <strong>routine DNA duplication and in response to genotoxic stress</strong>. </p>
<p>In summary, CHRAC1 functions at the crossroads of several fundamental pathways: it is a key adapter in <strong>ATP-dependent chromatin remodeling</strong>, it supports <strong>DNA replication-coupled chromatin assembly</strong>, and it likely plays auxiliary roles in <strong>transcription regulation and DNA repair</strong> by modulating nucleosome behavior. All these roles center on <strong>managing nucleosome positioning and stability</strong>, highlighting CHRAC1‚Äôs primary role as a structural keeper of chromatin states.</p>
<h2 id="cellular-localization">Cellular Localization</h2>
<p>CHRAC1 is an <strong>intracellular, nuclear protein</strong>. It lacks any signal peptides or transmembrane domains, and consistent with its role in chromatin dynamics, it localizes to the cell nucleus, predominantly in the nucleoplasm (the chromatin-containing portion of the nucleus) (<a href="https://www.proteinatlas.org/ENSG00000104472-CHRAC1#:~:text=Subcellular%20location,i%7D%20Low%20tissue%20specificity">www.proteinatlas.org</a>). High-resolution microscopy and cell fractionation experiments support this: CHRAC1 is found in the chromatin-bound fraction of nuclear extracts and co-localizes with known chromatin markers. For instance, as noted, components of the CHRAC complex including SNF2H and ACF1 (which would carry CHRAC1 with them) concentrate at <strong>pericentromeric heterochromatin foci</strong> marked by HP1 during S phase (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=Evidence%20from%20metazoan%20cells%20indicates,and%20BrdU%2C%20during%20S%20phase">pmc.ncbi.nlm.nih.gov</a>). Additionally, Pol Œµ (which shares the POLE3 subunit) localizes to <strong>replication foci</strong> that overlap with sites of DNA synthesis (PCNA/BrdU foci) in S phase (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=has%20been%20found%20in%20a,during%20which%20time%20heterochromatin%20is">pmc.ncbi.nlm.nih.gov</a>), and by proxy CHRAC may be present in those same foci to assist nucleosome assembly. Immunofluorescence studies in cancer cells also show CHRAC1 nuclear localization. In a recent study, CHRAC1 and YAP were observed to interact in the nucleus; CHRAC1 showed punctate nuclear staining and co-localized with YAP in transcriptionally active nuclear regions (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=activator%20Yes,were%20used%20to%20analyze%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in">pmc.ncbi.nlm.nih.gov</a>). No evidence exists for CHRAC1 functioning outside the nucleus‚Äîit is fundamentally tied to chromatin, which is a nuclear entity. Therefore, CHRAC1 carries out its function in the <strong>nuclear chromatin context</strong>, at sites where DNA is being read, copied, or repaired.</p>
<h2 id="recent-developments-and-clinical-significance">Recent Developments and Clinical Significance</h2>
<p>Emerging research, particularly in the last few years, has highlighted CHRAC1‚Äôs relevance in disease (notably cancer) and its potential as a therapeutic target. The <strong>CHRAC1 gene is located at 8q24.3</strong>, a chromosomal region frequently amplified in cancers. A 2014 oncogenomic study (Mahmood <em>et al.</em>, <em>Carcinogenesis</em> 2014) identified CHRAC1 as a <strong>driver gene within the 8q24.3 amplicon in breast cancer</strong> (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant">jeccr.biomedcentral.com</a>). In that RNA interference screen, CHRAC1 was one of a handful of genes whose knockdown impaired the proliferation and survival of breast cancer cells harboring the 8q24 amplification (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=siRNA%20screen%20identifies%20RAD21%2C%20EIF3H%2C,2014%3B35%3A670%E2%80%9382">jeccr.biomedcentral.com</a>). This indicates that overexpression of CHRAC1 can confer a growth advantage to tumor cells. Expanding on this, a <strong>pan-cancer analysis (2021)</strong> found that CHRAC1 and its complex members are frequently upregulated or amplified in multiple tumor types. Transcriptomic data from The Cancer Genome Atlas (TCGA) show <strong>concurrent overexpression of BAZ1A (ACF1), CHRAC1, and POLE3 in diverse cancers</strong> including esophageal carcinoma, hepatocellular carcinoma, gastric cancer, and breast carcinoma (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as">jeccr.biomedcentral.com</a>). In many tumors, at least two subunits of the CHRAC complex are aberrantly co-amplified or overexpressed, suggesting selective pressure to boost CHRAC activity in cancer cells (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=of%20abnormal%20copy%20numbers%20in,ESCC%2C%20while%20this%20region%20harbors">jeccr.biomedcentral.com</a>). This makes sense in light of CHRAC1‚Äôs function: increased chromatin remodeling capacity might enable cancer cells to more easily reprogram gene expression or tolerate replication stress. For example, CHRAC1 was found to be upregulated in <strong>cisplatin-resistant ovarian cancer cell lines and in metastatic lung tumors</strong>, with CHRAC1 knockdown reducing migration and invasion of those cancer cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=match%20at%20L108%20addition%2C%20CHRAC1,2021">pmc.ncbi.nlm.nih.gov</a>). These observations imply CHRAC1 contributes to therapy resistance and aggressive phenotypes, possibly by altering chromatin to activate survival pathways.</p>
<p>One of the most striking recent findings is CHRAC1‚Äôs connection to the <strong>Hippo signaling pathway</strong> via YAP. As mentioned, <strong>PeerJ (2024)</strong> reported that CHRAC1 physically interacts with YAP and enhances the transcription of YAP target genes, which include many pro-proliferative and anti-apoptotic factors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=Hippo%20pathway%2C%20thereby%20promoting%20tumorigenesis,YAP%20in%20breast%20and%20cervical">pmc.ncbi.nlm.nih.gov</a>). Functionally, silencing CHRAC1 in breast and cervical cancer models <strong>suppressed tumor cell proliferation and tumor growth in vivo</strong>, correlating with reduced expression of YAP-driven oncogenes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in">pmc.ncbi.nlm.nih.gov</a>). Clinically, CHRAC1 protein levels were found to be elevated in patient tumor samples (breast and cervical cancers), and high CHRAC1 expression was associated with <strong>poorer patient survival, higher tumor grade, and increased metastasis</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=match%20at%20L53%20Hippo%20pathway%2C,YAP%20in%20breast%20and%20cervical">pmc.ncbi.nlm.nih.gov</a>). This positions CHRAC1 as not only a biomarker of aggressive disease but also a potential <strong>therapeutic target</strong>. If CHRAC1 is required for the oncogenic gene expression program (like YAP‚Äôs program), drugs that inhibit the CHRAC complex or disrupt CHRAC1‚ÄìYAP interaction might curb tumor growth. Indeed, interest in targeting chromatin remodelers in cancer is growing, and CHRAC1 lies at the intersection of chromatin regulation and oncogenic signaling.</p>
<p>Beyond cancer, CHRAC1‚Äôs role in fundamental processes means that any dysregulation could have wide effects. As a coregulator of chromatin structure, CHRAC1 might be involved in disorders of genome instability or developmental epigenetic diseases, though these have not been well characterized yet. It‚Äôs worth noting that knocking out the <strong>mouse</strong> homolog of CHRAC1 has not been widely reported in literature ‚Äì given its role, a complete CHRAC1 knockout might be embryonic lethal or cause severe proliferation defects, which would align with it being a housekeeping gene. Consortium databases do indicate CHRAC1 is <strong>essential for cell viability</strong> in various cell lines (for instance, CRISPR screens list CHRAC1 among genes needed for growth in culture (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=of%20abnormal%20copy%20numbers%20in,ESCC%2C%20while%20this%20region%20harbors">jeccr.biomedcentral.com</a>)), reinforcing that it is not easily dispensable.</p>
<h2 id="expert-commentary-and-concluding-remarks">Expert Commentary and Concluding Remarks</h2>
<p>CHRAC1 exemplifies how small structural proteins can have outsized importance in genome regulation. As part of the ISWI-family chromatin remodelers, it <strong>alters the physical arrangement of nucleosomes</strong>, which is a fundamental mechanism for controlling access to DNA (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Chromatin%20remodeling%20complexes%20containing%20the,complexes%20via%20association%20with%20different">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=BAZ1A%20forms%20ACF%20complexes%20together,the%20ACF%20complex%2C%20BAZ1A%20stimulates">jeccr.biomedcentral.com</a>). Experts note that the <strong>sharing of a subunit between a chromatin remodeler and a DNA polymerase is a remarkable evolutionary solution</strong> to couple nucleosome dynamics with DNA replication (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=Two%20yeast%20homologs%20of%20ISWI%2C,for%20any%20of%20the%20HFM">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=has%20been%20found%20in%20a,during%20which%20time%20heterochromatin%20is">pmc.ncbi.nlm.nih.gov</a>). Dr. Zachary Pursell and Dr. Thomas Kunkel, in their comprehensive 2008 review of DNA Pol Œµ, highlighted the mystery of ‚Äúwhy two entirely separate enzymatic activities should have such a shared subunit‚Äù (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=homology%20to%20the%20unique%20HFM,the%20two%20complexes%2C%20but%20this">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=purified%20CHRAC%20in%20multiple%20species,that%20the%20human%20p12%2Fp17%20heterodimer">pmc.ncbi.nlm.nih.gov</a>). One hypothesis they offer is that the shared histone-fold subunit (POLE3/CHRAC17) could serve as a <strong>bridge between replication and chromatin assembly</strong>, ensuring that as the replication fork progresses, the chromatin structure is re-established immediately and correctly (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=propagate%20a%20silenced%20state%2C%20or,%CE%B5%20through%20Dpb4%2C%20with%20a">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=has%20been%20found%20in%20a,during%20which%20time%20heterochromatin%20is">pmc.ncbi.nlm.nih.gov</a>). CHRAC1, partnering in the CHRAC complex, appears to complement this by providing the chromatin remodeling horsepower needed especially in tightly packed regions. </p>
<p>Chromatin biology experts like Dr. Philippe Clapier have also underscored the importance of histone-fold proteins in chromatin transactions. In a 2017 review, Clapier <em>et al.</em> noted that histone-fold subunits (like CHRAC1 and its partners) not only serve as structural components but can act as <strong>‚Äúaccessory DNA-binding modules‚Äù that increase the efficiency and targeting of remodeling enzymes</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=chromatin%20accessibility%20complex%20subunit%201,In">pmc.ncbi.nlm.nih.gov</a>). The case of CHRAC1 validates this: without directly binding specific DNA sequences or catalyzing reactions, it nonetheless directs where and how the energy of SNF2H is applied on nucleosomes. </p>
<p>From a clinical perspective, cancer researchers (e.g. in the 2021 JECCR review) point out that ISWI complexes such as CHRAC are emerging as <strong>critical drivers in oncogenesis</strong> when deregulated (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=of%20abnormal%20copy%20numbers%20in,ESCC%2C%20while%20this%20region%20harbors">jeccr.biomedcentral.com</a>). The simultaneous up-regulation of CHRAC1 and its complex members in tumors suggests a selective advantage, possibly allowing cancer cells to rapidly restructure their chromatin for tumor-promoting gene expression programs (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant">jeccr.biomedcentral.com</a>). The fact that CHRAC1 has been confirmed as a key gene in a recurrent breast cancer amplification (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant">jeccr.biomedcentral.com</a>) and that its loss impairs tumor growth (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in">pmc.ncbi.nlm.nih.gov</a>) makes it an exciting candidate for targeted research. Therapies that inhibit chromatin remodelers (sometimes termed ‚Äúchromatin therapeutics‚Äù) could potentially exploit the cancer-specific dependency on CHRAC1. However, given CHRAC1‚Äôs essential role in normal cells, such approaches would require precision to avoid toxicity. </p>
<p>In conclusion, CHRAC1 is a <strong>multifaceted chromatin protein</strong> whose primary role is to support and enhance the machines that reorganize and replicate our genome. It anchors remodelers to nucleosomes, helping slide and assemble histones, and intersects with the replication fork to maintain chromatin continuity. Its activity is confined to the nucleus, where it safeguards genomic information flow ‚Äì from DNA packaging to gene expression and replication. Ongoing research, especially in oncology, continues to shed light on CHRAC1‚Äôs importance. As our understanding grows, CHRAC1 stands as a compelling example of how even the smallest protein components of chromatin complexes can have broad impacts on cell fate and function, making it both a <strong>fundamental piece of the chromatin infrastructure</strong> and a <strong>potential node to target in diseases of genome dysregulation</strong>.</p>
<p><strong>References:</strong> </p>
<ul>
<li>Bickmore WA &amp; Varga-Weisz PD. (2000). <em>EMBO J.</em> 19(11):3377‚Äì3387. ‚Äì Identification of human CHRAC complex containing hACF1 and two novel histone-fold proteins (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=CHRAC%20was%20initially%20purified%20from,disorganized%20nucleosomes%20formed%20in%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=remodeling%20complexes%20came%20with%20the,of%20human%20Pol%20%CE%B5%2C%20p12">pmc.ncbi.nlm.nih.gov</a>).  </li>
<li>Kukimoto I <em>et al.</em> (2004). <em>Molecular Cell</em> 13(2):265‚Äì277. ‚Äì Demonstrated that the CHRAC-15/17 histone-fold protein pair (human CHRAC1/POLE3) enhances ATP-dependent nucleosome sliding and assembly by ACF (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Furthermore%2C%20CHRAC1%20and%20POLE3%20interaction,CHRAC%20complex%20%5B63">jeccr.biomedcentral.com</a>).  </li>
<li>Pursell ZF &amp; Kunkel TA. (2008). <em>Prog. Nucleic Acid Res. Mol. Biol.</em> 82:101‚Äì145. ‚Äì Comprehensive review of DNA polymerase Œµ; discusses shared subunits between Pol Œµ and chromatin remodelers and their role in chromatin binding (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L922%20propagate%20a,%CE%B5%20through%20Dpb4%2C%20with%20a">pmc.ncbi.nlm.nih.gov</a>).  </li>
<li>Clapier CR <em>et al.</em> (2017). <em>Nat. Rev. Mol. Cell Biol.</em> 18(7):407‚Äì422. ‚Äì Review on mechanisms of chromatin remodeling; highlights the function of histone-fold subunits in remodeler targeting and activity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=chromatin%20accessibility%20complex%20subunit%201,In">pmc.ncbi.nlm.nih.gov</a>).  </li>
<li>Mahmood SF <em>et al.</em> (2014). <em>Carcinogenesis</em> 35(3):670‚Äì682. ‚Äì RNAi screen finding CHRAC1 as a driver gene within chromosome 8q24.3 amplification in breast cancer (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=siRNA%20screen%20identifies%20RAD21%2C%20EIF3H%2C,2014%3B35%3A670%E2%80%9382">jeccr.biomedcentral.com</a>).  </li>
<li>Li S <em>et al.</em> (2024). <em>PeerJ</em> 12:e16752 (Published Jan 10, 2024). ‚Äì Study showing CHRAC1 promotes YAP-mediated transcription in breast and cervical cancer; CHRAC1 knockdown inhibits tumor growth and correlates with better patient prognosis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=match%20at%20L53%20Hippo%20pathway%2C,YAP%20in%20breast%20and%20cervical">pmc.ncbi.nlm.nih.gov</a>).  </li>
<li>Song Y <em>et al.</em> (2021). <em>J. Exp. Clin. Cancer Res.</em> 40:346 (Published Nov 4, 2021). ‚Äì Review on ISWI chromatin remodeling complexes in cancer; reports frequent upregulation of CHRAC1 (with BAZ1A and POLE3) in tumors and discusses their potential oncogenic roles (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as">jeccr.biomedcentral.com</a>) (<a href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant">jeccr.biomedcentral.com</a>).  </li>
<li>Smith OK <em>et al.</em> (2018). <em>Mol. Cell</em> 70:707‚Äì721.e7. ‚Äì Showed that the POLE3‚ÄìPOLE4 subcomplex of Pol Œµ acts as a histone H3‚ÄìH4 chaperone during DNA replication, linking polymerase action to nucleosome assembly (<a href="https://pubmed.ncbi.nlm.nih.gov/30217558/#:~:text=Maintenance%20of%20epigenetic%20integrity%20relies,to%20selectively%20bind%20to%20histones">pubmed.ncbi.nlm.nih.gov</a>). (This provides insight into the function of the related CHRAC1‚ÄìPOLE3 pair in chromatin context.)</li>
</ul>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=705, start_index=498, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Chromatin%20remodeling%20complexes%20containing%20the,complexes%20via%20association%20with%20different')</li>
<li>AnnotationURLCitation(end_index=1066, start_index=879, title='The histone-fold protein complex CHRAC-15/17 enhances nucleosome sliding and assembly mediated by ACF. | BioGRID', type='url_citation', url='https://thebiogrid.org/114419/publication/the-histone-fold-protein-complex-chrac-1517-enhances-nucleosome-sliding-and-assembly-mediated-by-acf.html#:~:text=Read%20More')</li>
<li>AnnotationURLCitation(end_index=1239, start_index=1067, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=1418, start_index=1316, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=,DNA%20Interaction')</li>
<li>AnnotationURLCitation(end_index=1780, start_index=1652, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to')</li>
<li>AnnotationURLCitation(end_index=1950, start_index=1781, title='POLE3-POLE4 Is a Histone H3-H4 Chaperone that Maintains Chromatin Integrity during DNA Replication - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/30217558/#:~:text=Maintenance%20of%20epigenetic%20integrity%20relies,to%20selectively%20bind%20to%20histones')</li>
<li>AnnotationURLCitation(end_index=2303, start_index=2161, title='CHRAC1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000104472-CHRAC1#:~:text=Subcellular%20location,i%7D%20Low%20tissue%20specificity')</li>
<li>AnnotationURLCitation(end_index=2604, start_index=2462, title='CHRAC1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000104472-CHRAC1#:~:text=Subcellular%20location,i%7D%20Low%20tissue%20specificity')</li>
<li>AnnotationURLCitation(end_index=3287, start_index=3037, title='The histone-fold protein complex CHRAC-15/17 enhances nucleosome sliding and assembly mediated by ACF. | BioGRID', type='url_citation', url='https://thebiogrid.org/114419/publication/the-histone-fold-protein-complex-chrac-1517-enhances-nucleosome-sliding-and-assembly-mediated-by-acf.html#:~:text=%5BACF%5D%29%20associates%20with%20histone,17%20interacts%20with%20another')</li>
<li>AnnotationURLCitation(end_index=3460, start_index=3288, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=3650, start_index=3548, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=,DNA%20Interaction')</li>
<li>AnnotationURLCitation(end_index=3927, start_index=3825, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=,DNA%20Interaction')</li>
<li>AnnotationURLCitation(end_index=4253, start_index=4125, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to')</li>
<li>AnnotationURLCitation(end_index=4596, start_index=4468, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to')</li>
<li>AnnotationURLCitation(end_index=4950, start_index=4795, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L922%20propagate%20a,%CE%B5%20through%20Dpb4%2C%20with%20a')</li>
<li>AnnotationURLCitation(end_index=5695, start_index=5504, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=BAZ1A%20forms%20ACF%20complexes%20together,the%20ACF%20complex%2C%20BAZ1A%20stimulates')</li>
<li>AnnotationURLCitation(end_index=6007, start_index=5833, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=%28SMARCA1%2F5%20and%20RSF1%29%2C%20ACF,5%20%28SMARCA1%2F5%2C%20BAZ2B')</li>
<li>AnnotationURLCitation(end_index=6180, start_index=6008, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=6573, start_index=6323, title='The histone-fold protein complex CHRAC-15/17 enhances nucleosome sliding and assembly mediated by ACF. | BioGRID', type='url_citation', url='https://thebiogrid.org/114419/publication/the-histone-fold-protein-complex-chrac-1517-enhances-nucleosome-sliding-and-assembly-mediated-by-acf.html#:~:text=%5BACF%5D%29%20associates%20with%20histone,17%20interacts%20with%20another')</li>
<li>AnnotationURLCitation(end_index=6849, start_index=6688, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=remodeling%20complexes%20came%20with%20the,of%20human%20Pol%20%CE%B5%2C%20p12')</li>
<li>AnnotationURLCitation(end_index=6978, start_index=6850, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to')</li>
<li>AnnotationURLCitation(end_index=7337, start_index=7180, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=subunits%2C%20called%20p15%20and%20p17,of%20human%20Pol%20%CE%B5%2C%20p12')</li>
<li>AnnotationURLCitation(end_index=7494, start_index=7338, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=homology%20to%20the%20unique%20HFM,the%20two%20complexes%2C%20but%20this')</li>
<li>AnnotationURLCitation(end_index=7870, start_index=7709, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=remodeling%20complexes%20came%20with%20the,of%20human%20Pol%20%CE%B5%2C%20p12')</li>
<li>AnnotationURLCitation(end_index=8042, start_index=7871, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=purified%20CHRAC%20in%20multiple%20species,that%20the%20human%20p12%2Fp17%20heterodimer')</li>
<li>AnnotationURLCitation(end_index=8291, start_index=8130, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=remodeling%20complexes%20came%20with%20the,of%20human%20Pol%20%CE%B5%2C%20p12')</li>
<li>AnnotationURLCitation(end_index=8448, start_index=8292, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=homology%20to%20the%20unique%20HFM,the%20two%20complexes%2C%20but%20this')</li>
<li>AnnotationURLCitation(end_index=8860, start_index=8673, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=together%20with%20Ioc2%20and%20Ioc4,activation%20until%20signal%20thresholds%20are')</li>
<li>AnnotationURLCitation(end_index=9627, start_index=9455, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=9808, start_index=9628, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Furthermore%2C%20CHRAC1%20and%20POLE3%20interaction,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=10241, start_index=10069, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=10422, start_index=10242, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Furthermore%2C%20CHRAC1%20and%20POLE3%20interaction,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=10835, start_index=10585, title='The histone-fold protein complex CHRAC-15/17 enhances nucleosome sliding and assembly mediated by ACF. | BioGRID', type='url_citation', url='https://thebiogrid.org/114419/publication/the-histone-fold-protein-complex-chrac-1517-enhances-nucleosome-sliding-and-assembly-mediated-by-acf.html#:~:text=%5BACF%5D%29%20associates%20with%20histone,17%20interacts%20with%20another')</li>
<li>AnnotationURLCitation(end_index=11008, start_index=10836, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=11368, start_index=11118, title='The histone-fold protein complex CHRAC-15/17 enhances nucleosome sliding and assembly mediated by ACF. | BioGRID', type='url_citation', url='https://thebiogrid.org/114419/publication/the-histone-fold-protein-complex-chrac-1517-enhances-nucleosome-sliding-and-assembly-mediated-by-acf.html#:~:text=%5BACF%5D%29%20associates%20with%20histone,17%20interacts%20with%20another')</li>
<li>AnnotationURLCitation(end_index=11909, start_index=11740, title='POLE3-POLE4 Is a Histone H3-H4 Chaperone that Maintains Chromatin Integrity during DNA Replication - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/30217558/#:~:text=Maintenance%20of%20epigenetic%20integrity%20relies,to%20selectively%20bind%20to%20histones')</li>
<li>AnnotationURLCitation(end_index=12299, start_index=12130, title='POLE3-POLE4 Is a Histone H3-H4 Chaperone that Maintains Chromatin Integrity during DNA Replication - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/30217558/#:~:text=Maintenance%20of%20epigenetic%20integrity%20relies,to%20selectively%20bind%20to%20histones')</li>
<li>AnnotationURLCitation(end_index=12743, start_index=12615, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to')</li>
<li>AnnotationURLCitation(end_index=13842, start_index=13680, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L879%20CHRAC%20was,disorganized%20nucleosomes%20formed%20in%20the')</li>
<li>AnnotationURLCitation(end_index=14232, start_index=14060, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=CHRAC%20was%20initially%20purified%20from,disorganized%20nucleosomes%20formed%20in%20the')</li>
<li>AnnotationURLCitation(end_index=14665, start_index=14458, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Chromatin%20remodeling%20complexes%20containing%20the,complexes%20via%20association%20with%20different')</li>
<li>AnnotationURLCitation(end_index=14857, start_index=14666, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=BAZ1A%20forms%20ACF%20complexes%20together,the%20ACF%20complex%2C%20BAZ1A%20stimulates')</li>
<li>AnnotationURLCitation(end_index=15229, start_index=15057, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=15410, start_index=15230, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Furthermore%2C%20CHRAC1%20and%20POLE3%20interaction,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=15737, start_index=15565, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=16515, start_index=16308, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Chromatin%20remodeling%20complexes%20containing%20the,complexes%20via%20association%20with%20different')</li>
<li>AnnotationURLCitation(end_index=16975, start_index=16825, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in')</li>
<li>AnnotationURLCitation(end_index=17152, start_index=16976, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=Hippo%20pathway%2C%20thereby%20promoting%20tumorigenesis,YAP%20in%20breast%20and%20cervical')</li>
<li>AnnotationURLCitation(end_index=17511, start_index=17361, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in')</li>
<li>AnnotationURLCitation(end_index=17669, start_index=17512, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=match%20at%20L53%20Hippo%20pathway%2C,YAP%20in%20breast%20and%20cervical')</li>
<li>AnnotationURLCitation(end_index=18023, start_index=17873, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in')</li>
<li>AnnotationURLCitation(end_index=18200, start_index=18024, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=Hippo%20pathway%2C%20thereby%20promoting%20tumorigenesis,YAP%20in%20breast%20and%20cervical')</li>
<li>AnnotationURLCitation(end_index=19122, start_index=18953, title='POLE3-POLE4 Is a Histone H3-H4 Chaperone that Maintains Chromatin Integrity during DNA Replication - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/30217558/#:~:text=Maintenance%20of%20epigenetic%20integrity%20relies,to%20selectively%20bind%20to%20histones')</li>
<li>AnnotationURLCitation(end_index=19867, start_index=19702, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=Evidence%20from%20metazoan%20cells%20indicates,and%20BrdU%2C%20during%20S%20phase')</li>
<li>AnnotationURLCitation(end_index=20352, start_index=20196, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=has%20been%20found%20in%20a,during%20which%20time%20heterochromatin%20is')</li>
<li>AnnotationURLCitation(end_index=20690, start_index=20528, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=propagate%20a%20silenced%20state%2C%20or,%CE%B5%20through%20Dpb4%2C%20with%20a')</li>
<li>AnnotationURLCitation(end_index=20847, start_index=20691, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=has%20been%20found%20in%20a,during%20which%20time%20heterochromatin%20is')</li>
<li>AnnotationURLCitation(end_index=21225, start_index=21064, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=this%20region%20in%20opposition%20to,silencing%20and%20activation%20in%20this')</li>
<li>AnnotationURLCitation(end_index=21606, start_index=21451, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L922%20propagate%20a,%CE%B5%20through%20Dpb4%2C%20with%20a')</li>
<li>AnnotationURLCitation(end_index=21769, start_index=21607, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=propagate%20a%20silenced%20state%2C%20or,%CE%B5%20through%20Dpb4%2C%20with%20a')</li>
<li>AnnotationURLCitation(end_index=22305, start_index=22136, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=CHRAC%20may%20also%20contribute%2C%20directly,to%20rearrange%20the%20nucleosomes%20on')</li>
<li>AnnotationURLCitation(end_index=23113, start_index=22932, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=In%20normal%20cells%2C%20BAZ1A%20is,strand%20breaks%20%28DSBs%29%20and%20DSB')</li>
<li>AnnotationURLCitation(end_index=23300, start_index=23114, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=the%20KU70%2F80%20complex%20and%20formation,disruption%20of%20the%20ACF%20complex')</li>
<li>AnnotationURLCitation(end_index=23856, start_index=23700, title='The loss of DNA polymerase epsilon accessory subunits POLE3‚ÄìPOLE4 leads to BRCA1-independent PARP inhibitor sensitivity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11229324/#:~:text=The%20loss%20of%20DNA%20polymerase,the%20levels%20of%20POLE3%2C%20POLE4')</li>
<li>AnnotationURLCitation(end_index=23989, start_index=23857, title='The loss of DNA polymerase epsilon accessory subunits POLE3‚ÄìPOLE4 leads to BRCA1-independent PARP inhibitor sensitivity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11229324/#:~:text=Figure%201,the%20levels%20of%20POLE3%2C%20POLE4')</li>
<li>AnnotationURLCitation(end_index=25213, start_index=25071, title='CHRAC1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000104472-CHRAC1#:~:text=Subcellular%20location,i%7D%20Low%20tissue%20specificity')</li>
<li>AnnotationURLCitation(end_index=25774, start_index=25609, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=Evidence%20from%20metazoan%20cells%20indicates,and%20BrdU%2C%20during%20S%20phase')</li>
<li>AnnotationURLCitation(end_index=26088, start_index=25932, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=has%20been%20found%20in%20a,during%20which%20time%20heterochromatin%20is')</li>
<li>AnnotationURLCitation(end_index=26575, start_index=26442, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=activator%20Yes,were%20used%20to%20analyze%20the')</li>
<li>AnnotationURLCitation(end_index=26726, start_index=26576, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in')</li>
<li>AnnotationURLCitation(end_index=27593, start_index=27451, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant')</li>
<li>AnnotationURLCitation(end_index=27919, start_index=27777, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant')</li>
<li>AnnotationURLCitation(end_index=28101, start_index=27920, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=siRNA%20screen%20identifies%20RAD21%2C%20EIF3H%2C,2014%3B35%3A670%E2%80%9382')</li>
<li>AnnotationURLCitation(end_index=28777, start_index=28593, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as')</li>
<li>AnnotationURLCitation(end_index=28962, start_index=28778, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as')</li>
<li>AnnotationURLCitation(end_index=29323, start_index=29139, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as')</li>
<li>AnnotationURLCitation(end_index=29506, start_index=29324, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=of%20abnormal%20copy%20numbers%20in,ESCC%2C%20while%20this%20region%20harbors')</li>
<li>AnnotationURLCitation(end_index=30033, start_index=29903, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=match%20at%20L108%20addition%2C%20CHRAC1,2021')</li>
<li>AnnotationURLCitation(end_index=30647, start_index=30497, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in')</li>
<li>AnnotationURLCitation(end_index=30824, start_index=30648, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=Hippo%20pathway%2C%20thereby%20promoting%20tumorigenesis,YAP%20in%20breast%20and%20cervical')</li>
<li>AnnotationURLCitation(end_index=31170, start_index=31020, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in')</li>
<li>AnnotationURLCitation(end_index=31566, start_index=31409, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=match%20at%20L53%20Hippo%20pathway%2C,YAP%20in%20breast%20and%20cervical')</li>
<li>AnnotationURLCitation(end_index=32959, start_index=32775, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as')</li>
<li>AnnotationURLCitation(end_index=33142, start_index=32960, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=of%20abnormal%20copy%20numbers%20in,ESCC%2C%20while%20this%20region%20harbors')</li>
<li>AnnotationURLCitation(end_index=33713, start_index=33506, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Chromatin%20remodeling%20complexes%20containing%20the,complexes%20via%20association%20with%20different')</li>
<li>AnnotationURLCitation(end_index=33905, start_index=33714, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=BAZ1A%20forms%20ACF%20complexes%20together,the%20ACF%20complex%2C%20BAZ1A%20stimulates')</li>
<li>AnnotationURLCitation(end_index=34242, start_index=34094, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=Two%20yeast%20homologs%20of%20ISWI%2C,for%20any%20of%20the%20HFM')</li>
<li>AnnotationURLCitation(end_index=34399, start_index=34243, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=has%20been%20found%20in%20a,during%20which%20time%20heterochromatin%20is')</li>
<li>AnnotationURLCitation(end_index=34759, start_index=34603, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=homology%20to%20the%20unique%20HFM,the%20two%20complexes%2C%20but%20this')</li>
<li>AnnotationURLCitation(end_index=34931, start_index=34760, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=purified%20CHRAC%20in%20multiple%20species,that%20the%20human%20p12%2Fp17%20heterodimer')</li>
<li>AnnotationURLCitation(end_index=35367, start_index=35205, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=propagate%20a%20silenced%20state%2C%20or,%CE%B5%20through%20Dpb4%2C%20with%20a')</li>
<li>AnnotationURLCitation(end_index=35524, start_index=35368, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=has%20been%20found%20in%20a,during%20which%20time%20heterochromatin%20is')</li>
<li>AnnotationURLCitation(end_index=36223, start_index=36086, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=chromatin%20accessibility%20complex%20subunit%201,In')</li>
<li>AnnotationURLCitation(end_index=36796, start_index=36612, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as')</li>
<li>AnnotationURLCitation(end_index=36979, start_index=36797, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=of%20abnormal%20copy%20numbers%20in,ESCC%2C%20while%20this%20region%20harbors')</li>
<li>AnnotationURLCitation(end_index=37387, start_index=37203, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as')</li>
<li>AnnotationURLCitation(end_index=37530, start_index=37388, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant')</li>
<li>AnnotationURLCitation(end_index=37771, start_index=37629, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant')</li>
<li>AnnotationURLCitation(end_index=37961, start_index=37811, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in')</li>
<li>AnnotationURLCitation(end_index=39512, start_index=39340, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=CHRAC%20was%20initially%20purified%20from,disorganized%20nucleosomes%20formed%20in%20the')</li>
<li>AnnotationURLCitation(end_index=39674, start_index=39513, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=remodeling%20complexes%20came%20with%20the,of%20human%20Pol%20%CE%B5%2C%20p12')</li>
<li>AnnotationURLCitation(end_index=40057, start_index=39885, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=match%20at%20L373%20Furthermore%2C%20CHRAC1,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=40238, start_index=40058, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Furthermore%2C%20CHRAC1%20and%20POLE3%20interaction,CHRAC%20complex%20%5B63')</li>
<li>AnnotationURLCitation(end_index=40598, start_index=40470, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L914%20%CE%B5%20and,linked%20to')</li>
<li>AnnotationURLCitation(end_index=40754, start_index=40599, title='DNA Polymerase Œµ: A Polymerase Of Unusual Size (and Complexity) - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3694787/#:~:text=match%20at%20L922%20propagate%20a,%CE%B5%20through%20Dpb4%2C%20with%20a')</li>
<li>AnnotationURLCitation(end_index=41101, start_index=40964, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=chromatin%20accessibility%20complex%20subunit%201,In')</li>
<li>AnnotationURLCitation(end_index=41411, start_index=41269, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant')</li>
<li>AnnotationURLCitation(end_index=41593, start_index=41412, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=siRNA%20screen%20identifies%20RAD21%2C%20EIF3H%2C,2014%3B35%3A670%E2%80%9382')</li>
<li>AnnotationURLCitation(end_index=41989, start_index=41839, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=In%20the%20current%20study%2C%20we,of%20YAP%20target%20genes%20in')</li>
<li>AnnotationURLCitation(end_index=42147, start_index=41990, title='Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10787542/#:~:text=match%20at%20L53%20Hippo%20pathway%2C,YAP%20in%20breast%20and%20cervical')</li>
<li>AnnotationURLCitation(end_index=42599, start_index=42415, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=Through%20TCGA%20database%20analysis%2C%20we,kinds%20of%20tumors%2C%20such%20as')</li>
<li>AnnotationURLCitation(end_index=42742, start_index=42600, title='The emerging role of ISWI chromatin remodeling complexes in cancer | Journal of Experimental &amp; Clinical Cancer Research | Full Text', type='url_citation', url='https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02151-x#:~:text=some%20oncogenic%20genes%20,resistant')</li>
<li>AnnotationURLCitation(end_index=43127, start_index=42958, title='POLE3-POLE4 Is a Histone H3-H4 Chaperone that Maintains Chromatin Integrity during DNA Replication - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/30217558/#:~:text=Maintenance%20of%20epigenetic%20integrity%20relies,to%20selectively%20bind%20to%20histones')</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q9NRG0
gene_symbol: CHRAC1
product_type: PROTEIN
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  CHRAC1 (Chromatin Accessibility Complex protein 1, also known as CHRAC-15 or CHRAC15)
  is a small (~15 kDa, 131 amino acids) histone-fold protein that functions as a
  structural/accessory subunit in the CHRAC (Chromatin Accessibility Complex)
  ATP-dependent chromatin remodeling complex. CHRAC1 forms a stable heterodimer with
  POLE3 (also known as CHRAC-17/p17) via their histone-fold domains, structurally
  analogous to the histone H2A-H2B dimer. This CHRAC1-POLE3 heterodimer binds naked
  double-stranded DNA and associates with the ACF chromatin remodeling complex
  (consisting of SMARCA5/SNF2H and BAZ1A/ACF1) to form the complete four-subunit
  CHRAC complex. The CHRAC1-POLE3 module enhances the ATP-dependent nucleosome
  sliding and chromatin assembly activities of ACF. CHRAC1 itself has no enzymatic
  activity but serves as an essential adapter that tethers the remodeling machinery
  to chromatin substrates. The complex functions in chromatin remodeling during DNA
  replication (particularly through heterochromatin), transcriptional regulation,
  and maintenance of chromatin organization.
existing_annotations:
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        CHRAC1 is a nuclear protein that functions in chromatin remodeling. The Human
        Protein Atlas confirms nuclear/nucleoplasm localization. UniProt states
        &#34;Nucleus&#34; for subcellular location. This is well-supported by its role as
        a subunit of the nuclear CHRAC chromatin remodeling complex [PMID:10880450].
      action: ACCEPT
      reason: &gt;-
        Nuclear localization is strongly supported by CHRAC1&#39;s established role as
        a
        subunit of the CHRAC complex, which functions in the nucleus on chromatin.
        IBA inference is consistent with experimental data showing CHRAC1 is a
        chromatin-associated nuclear protein.
      supported_by:
        - reference_id: file:human/CHRAC1/CHRAC1-deep-research-openai.md
          supporting_text: &gt;-
            CHRAC1 is an intracellular, nuclear protein. It lacks any signal peptides
            or transmembrane domains, and consistent with its role in chromatin dynamics,
            it localizes to the cell nucleus, predominantly in the nucleoplasm

  - term:
      id: GO:0006261
      label: DNA-templated DNA replication
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        CHRAC1 is part of the CHRAC complex which facilitates DNA replication through
        heterochromatin by remodeling nucleosomes. The ACF1-ISWI complex (part of
        CHRAC)
        is required for DNA replication through pericentromeric heterochromatin
        [PMID:12434153]. However, CHRAC1 does not directly participate in DNA synthesis;
        it facilitates chromatin accessibility for the replication machinery.
      action: MODIFY
      reason: &gt;-
        While CHRAC1&#39;s complex facilitates DNA replication through chromatin, the
        term
        &#34;DNA-templated DNA replication&#34; implies direct involvement in DNA synthesis.
        CHRAC1 functions in chromatin remodeling to support replication, not in
        replication itself. A more accurate term would be &#34;regulation of DNA replication&#34;
        or chromatin remodeling during replication.
      proposed_replacement_terms:
        - id: GO:0006275
          label: regulation of DNA replication
      supported_by:
        - reference_id: PMID:12434153
          supporting_text: &gt;-
            an ACF1-ISWI chromatin-remodeling complex is required for replication
            through heterochromatin in mammalian cells

  - term:
      id: GO:0006338
      label: chromatin remodeling
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        CHRAC1 is a core subunit of the CHRAC chromatin remodeling complex. The
        CHRAC1-POLE3 heterodimer enhances ATP-dependent nucleosome sliding and
        chromatin assembly mediated by ACF [PMID:14759371]. This is a primary
        function of CHRAC1.
      action: ACCEPT
      reason: &gt;-
        Chromatin remodeling is the core function of the CHRAC complex of which
        CHRAC1 is an essential structural subunit. Multiple publications confirm
        CHRAC1&#39;s role in facilitating nucleosome sliding and chromatin reorganization.
      supported_by:
        - reference_id: PMID:14759371
          supporting_text: &gt;-
            these histone-fold proteins facilitate ATP-dependent nucleosome sliding
            by ACF

  - term:
      id: GO:0008623
      label: CHRAC
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: &gt;-
        CHRAC1 is a defining component of the CHRAC (Chromatin Accessibility Complex).
        It was identified as part of HuCHRAC along with SMARCA5, BAZ1A, and POLE3
        [PMID:10880450]. This is the eponymous complex for CHRAC1.
      action: ACCEPT
      reason: &gt;-
        CHRAC1 is one of the four subunits that compose the CHRAC complex (along with
        SMARCA5/SNF2H, BAZ1A/ACF1, and POLE3). This cellular component annotation
        is
        directly supported by the original publication describing human CHRAC.
      supported_by:
        - reference_id: PMID:10880450
          supporting_text: &gt;-
            the human homologues of two novel putative histone-fold proteins in
            Drosophila CHRAC are present in HuCHRAC

  - term:
      id: GO:0003677
      label: DNA binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: &gt;-
        CHRAC1 forms a heterodimer with POLE3 that binds naked double-stranded DNA.
        This is experimentally demonstrated in the original HuCHRAC characterization
        [PMID:10880450]. The annotation is correct but could be more specific.
      action: ACCEPT
      reason: &gt;-
        While DNA binding is accurate, CHRAC1-POLE3 specifically binds double-stranded
        DNA, not nucleosomal DNA. A more specific term would be more informative,
        but this annotation is not incorrect.
      supported_by:
        - reference_id: PMID:10880450
          supporting_text: &gt;-
            two human histone-fold proteins form a stable complex that binds naked
            DNA
            but not nucleosomes

  - term:
      id: GO:0003887
      label: DNA-directed DNA polymerase activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: &gt;-
        CHRAC1 does NOT have DNA polymerase activity. This annotation is based on
        UniProt keyword mapping that is incorrect. CHRAC1 is a histone-fold structural
        protein with no catalytic activity. Its partner POLE3 is shared with DNA
        polymerase epsilon, but CHRAC1 itself is not a polymerase component.
      action: REMOVE
      reason: &gt;-
        This is an erroneous annotation. CHRAC1 has no enzymatic activity and is not
        a DNA polymerase. The confusion likely arises because POLE3 (CHRAC1&#39;s binding
        partner) is also a subunit of DNA polymerase epsilon, but CHRAC1 is specific
        to the CHRAC complex and is not part of Pol epsilon.
      supported_by:
        - reference_id: PMID:14759371
          supporting_text: &gt;-
            CHRAC-17 interacts with another histone-fold protein, p12, in DNA polymerase
            epsilon, but CHRAC-15 is essential for interaction with ACF

  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: &gt;-
        Duplicate annotation of nuclear localization via UniProt subcellular location
        mapping. Correct annotation but redundant with the IBA annotation.
      action: ACCEPT
      reason: &gt;-
        Nuclear localization is accurate for CHRAC1. The duplicate evidence codes
        (IBA and IEA) both correctly identify the nuclear localization.
      supported_by:
        - reference_id: file:human/CHRAC1/CHRAC1-deep-research-openai.md
          supporting_text: &gt;-
            CHRAC1 is an intracellular, nuclear protein

  - term:
      id: GO:0016740
      label: transferase activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: &gt;-
        CHRAC1 does NOT have transferase activity. This is an erroneous annotation
        derived from incorrect UniProt keyword mapping. CHRAC1 is a non-enzymatic
        histone-fold protein that serves as a structural adapter in chromatin
        remodeling complexes.
      action: REMOVE
      reason: &gt;-
        CHRAC1 has no catalytic activity whatsoever. It is a structural subunit that
        binds DNA and enhances the activity of the CHRAC complex&#39;s ATPase (SMARCA5),
        but has no enzymatic function itself. This annotation is completely incorrect.

  - term:
      id: GO:0016779
      label: nucleotidyltransferase activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: &gt;-
        CHRAC1 does NOT have nucleotidyltransferase activity. This annotation is
        erroneous, likely derived from the same incorrect keyword mapping that
        generated the DNA polymerase and transferase annotations.
      action: REMOVE
      reason: &gt;-
        CHRAC1 is a non-enzymatic structural protein. It has no nucleotidyltransferase
        or any other enzymatic activity. This annotation should be removed as it
        misrepresents the function of CHRAC1.

  - term:
      id: GO:0046982
      label: protein heterodimerization activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    review:
      summary: &gt;-
        CHRAC1 forms a stable heterodimer with POLE3 (CHRAC-17) via their histone-fold
        domains. This interaction is well-documented and essential for CHRAC1 function
        [PMID:10880450, PMID:14759371]. The annotation is accurate.
      action: ACCEPT
      reason: &gt;-
        Heterodimerization with POLE3 is a core biochemical property of CHRAC1.
        The CHRAC1-POLE3 heterodimer is analogous to the H2A-H2B histone dimer and
        is essential for DNA binding and interaction with the ACF complex.
      supported_by:
        - reference_id: PMID:14759371
          supporting_text: &gt;-
            CHRAC-17 interacts with another histone-fold protein, p12, in DNA polymerase
            epsilon, but CHRAC-15 is essential for interaction with ACF

  - term:
      id: GO:0071897
      label: DNA biosynthetic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000108
    review:
      summary: &gt;-
        CHRAC1 is not directly involved in DNA biosynthesis. This annotation appears
        to be derived from logical inference that is not accurate for CHRAC1&#39;s actual
        function. CHRAC1 facilitates chromatin remodeling during replication but does
        not participate in DNA synthesis.
      action: REMOVE
      reason: &gt;-
        CHRAC1 does not synthesize DNA. While the CHRAC complex facilitates DNA
        replication by remodeling chromatin, CHRAC1 itself does not have any role
        in
        the actual biosynthesis of DNA. This annotation conflates the complex&#39;s role
        in supporting replication with direct participation in DNA synthesis.

  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21516116
    review:
      summary: &gt;-
        This annotation is from a large-scale interactome study. While CHRAC1 does
        bind proteins (POLE3, SMARCA5, BAZ1A), &#34;protein binding&#34; is too vague and
        uninformative for curation purposes.
      action: REMOVE
      reason: &gt;-
        GO:0005515 (protein binding) is considered uninformative per GO curation
        guidelines. CHRAC1&#39;s specific protein interactions (heterodimerization with
        POLE3, interaction with ACF1/BAZ1A) are captured by more specific terms.

      supported_by:
        - reference_id: PMID:21516116
          supporting_text: Next-generation sequencing to generate interactome 
            datasets.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:25416956
    review:
      summary: &gt;-
        Large-scale proteome interactome study. The &#34;protein binding&#34; term is
        uninformative and should not be used for annotation.
      action: REMOVE
      reason: &gt;-
        GO:0005515 (protein binding) is considered too vague per GO guidelines.
        High-throughput interactome studies do not provide sufficient specificity
        for meaningful functional annotation.

      supported_by:
        - reference_id: PMID:25416956
          supporting_text: A proteome-scale map of the human interactome 
            network.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:31515488
    review:
      summary: &gt;-
        Interactome study on genetic variants. The generic &#34;protein binding&#34;
        annotation is uninformative.
      action: REMOVE
      reason: &gt;-
        GO:0005515 (protein binding) should be avoided as it provides no specific
        functional information. CHRAC1&#39;s important protein interactions are better
        captured by heterodimerization activity and complex membership annotations.

      supported_by:
        - reference_id: PMID:31515488
          supporting_text: Extensive disruption of protein interactions by 
            genetic variants across the allele frequency spectrum in human 
            populations.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:32296183
    review:
      summary: &gt;-
        Binary protein interactome reference map study. Generic protein binding
        annotation is uninformative.
      action: REMOVE
      reason: &gt;-
        GO:0005515 should not be used for annotation. CHRAC1&#39;s specific binding
        partners and functions are already captured by more informative terms.

      supported_by:
        - reference_id: PMID:32296183
          supporting_text: Apr 8. A reference map of the human binary protein 
            interactome.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:33961781
    review:
      summary: &gt;-
        Dual proteome-scale interactome network study. Protein binding is
        uninformative as a molecular function annotation.
      action: REMOVE
      reason: &gt;-
        GO:0005515 (protein binding) provides no specific functional insight.
        This generic term should be replaced by more specific molecular function
        terms that describe CHRAC1&#39;s actual interactions.

      supported_by:
        - reference_id: PMID:33961781
          supporting_text: 2021 May 6. Dual proteome-scale networks reveal 
            cell-specific remodeling of the human interactome.
  - term:
      id: GO:0005721
      label: pericentric heterochromatin
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: &gt;-
        The CHRAC complex (containing CHRAC1) localizes to pericentric heterochromatin
        during late S phase when this region is replicated. ACF1 and SNF2H colocalize
        with heterochromatin and BrdU during S phase [PMID:12434153].
      action: ACCEPT
      reason: &gt;-
        CHRAC1 is part of the CHRAC complex which is specifically recruited to
        pericentromeric heterochromatin during DNA replication. This localization
        is functionally relevant for CHRAC&#39;s role in facilitating replication through
        condensed chromatin.
      supported_by:
        - reference_id: PMID:12434153
          supporting_text: &gt;-
            ACF1 (ATP-utilizing chromatin assembly and remodeling factor 1) and an
            ISWI isoform, SNF2H (sucrose nonfermenting-2 homolog), become specifically
            enriched in replicating pericentromeric heterochromatin

  - term:
      id: GO:0005721
      label: pericentric heterochromatin
    evidence_type: ISO
    original_reference_id: GO_REF:0000114
    review:
      summary: &gt;-
        Manual transfer of heterochromatin localization from homologous complexes.
        This is consistent with CHRAC&#39;s established role in heterochromatin replication.
      action: ACCEPT
      reason: &gt;-
        Pericentric heterochromatin localization is supported by experimental data
        for the CHRAC complex, making this ISO annotation well-justified. The complex
        is enriched at heterochromatin during late S-phase replication.
      supported_by:
        - reference_id: PMID:12434153
          supporting_text: &gt;-
            RNAi-mediated depletion of ACF1 specifically impairs the replication
            of pericentromeric heterochromatin

  - term:
      id: GO:0006275
      label: regulation of DNA replication
    evidence_type: IMP
    original_reference_id: PMID:12434153
    review:
      summary: &gt;-
        This annotation is based on the study showing that depletion of ACF1 (CHRAC
        component) impairs replication of pericentromeric heterochromatin and delays
        cell cycle progression through late S phase [PMID:12434153]. CHRAC1 is part
        of this complex.
      action: ACCEPT
      reason: &gt;-
        The CHRAC complex, of which CHRAC1 is a subunit, regulates DNA replication
        by facilitating replication through heterochromatin. Loss of complex components
        leads to replication defects, demonstrating a regulatory role.
      supported_by:
        - reference_id: PMID:12434153
          supporting_text: &gt;-
            depletion of ACF1 causes a delay in cell-cycle progression through the
            late stages of S phase

  - term:
      id: GO:0006334
      label: nucleosome assembly
    evidence_type: IDA
    original_reference_id: PMID:14759371
    review:
      summary: &gt;-
        CHRAC1 (as part of the CHRAC1-POLE3 complex) facilitates chromatin assembly
        mediated by ACF. The study shows that CHRAC-15/17, p12/CHRAC-17, and NC2
        complexes facilitate ACF-mediated chromatin assembly [PMID:14759371].
      action: ACCEPT
      reason: &gt;-
        Nucleosome assembly is a core function of the CHRAC complex. The CHRAC1-POLE3
        heterodimer enhances the chromatin assembly activity of ACF, making this a
        valid molecular function of CHRAC1.
      supported_by:
        - reference_id: PMID:14759371
          supporting_text: &gt;-
            CHRAC-15/17, p12/CHRAC-17, and NC2 complexes facilitate ACF-mediated
            chromatin assembly by a mechanism different from nucleosome sliding enhancement

  - term:
      id: GO:0006338
      label: chromatin remodeling
    evidence_type: IDA
    original_reference_id: PMID:10880450
    review:
      summary: &gt;-
        The original publication identifying HuCHRAC demonstrates that this complex
        has ATP-dependent chromatin remodeling activity. CHRAC1 is an essential
        subunit of this complex [PMID:10880450].
      action: ACCEPT
      reason: &gt;-
        Chromatin remodeling is the defining function of the CHRAC complex. This IDA
        annotation from the original characterization paper is well-supported.
      supported_by:
        - reference_id: PMID:10880450
          supporting_text: &gt;-
            HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and
            two novel histone-fold proteins

  - term:
      id: GO:0008623
      label: CHRAC
    evidence_type: NAS
    original_reference_id: PMID:10880450
    review:
      summary: &gt;-
        This NAS annotation for CHRAC complex membership is from the same publication
        that identified HuCHRAC. While NAS is a weaker evidence code, the data clearly
        supports CHRAC1 as a CHRAC subunit.
      action: ACCEPT
      reason: &gt;-
        CHRAC1 is definitionally a component of the CHRAC complex - it is named for
        this complex (CHRAC-15). The original publication provides direct evidence
        for this complex membership.
      supported_by:
        - reference_id: PMID:10880450
          supporting_text: &gt;-
            the human homologues of two novel putative histone-fold proteins in
            Drosophila CHRAC are present in HuCHRAC

  - term:
      id: GO:0003887
      label: DNA-directed DNA polymerase activity
    evidence_type: NAS
    original_reference_id: PMID:10880450
    review:
      summary: &gt;-
        This NAS annotation is INCORRECT. PMID:10880450 does not claim that CHRAC1
        has DNA polymerase activity. The publication describes CHRAC1 as a histone-fold
        protein in a chromatin remodeling complex, not as an enzyme.
      action: REMOVE
      reason: &gt;-
        This annotation is erroneous. CHRAC1 has no DNA polymerase activity. The
        original publication (PMID:10880450) describes CHRAC1 as a structural
        histone-fold protein, not an enzyme. The confusion may arise from POLE3&#39;s
        dual role in Pol epsilon, but CHRAC1 is not part of the polymerase complex.
      supported_by:
        - reference_id: PMID:14759371
          supporting_text: &gt;-
            CHRAC-17 interacts with another histone-fold protein, p12, in DNA polymerase
            epsilon, but CHRAC-15 is essential for interaction with ACF

        - reference_id: PMID:10880450
          supporting_text: HuCHRAC, a human ISWI chromatin remodelling complex 
            contains hACF1 and two novel histone-fold proteins.
  - term:
      id: GO:0008622
      label: epsilon DNA polymerase complex
    evidence_type: NAS
    original_reference_id: PMID:10880450
    review:
      summary: &gt;-
        This annotation is INCORRECT. CHRAC1 is NOT a component of DNA polymerase
        epsilon. POLE3 (CHRAC1&#39;s binding partner) is shared between CHRAC and Pol
        epsilon, but CHRAC1 itself is specific to the CHRAC complex [PMID:14759371].
      action: REMOVE
      reason: &gt;-
        CHRAC1 is not a subunit of DNA polymerase epsilon. While POLE3 (p17) is
        shared between CHRAC and Pol epsilon, CHRAC1 (p15) is unique to CHRAC.
        The original literature clearly distinguishes CHRAC1 from Pol epsilon
        components.
      supported_by:
        - reference_id: PMID:14759371
          supporting_text: &gt;-
            CHRAC-17 interacts with another histone-fold protein, p12, in DNA
            polymerase epsilon, but CHRAC-15 is essential for interaction with ACF

        - reference_id: PMID:10880450
          supporting_text: HuCHRAC, a human ISWI chromatin remodelling complex 
            contains hACF1 and two novel histone-fold proteins.
  - term:
      id: GO:0003677
      label: DNA binding
    evidence_type: NAS
    original_reference_id: PMID:10880450
    review:
      summary: &gt;-
        DNA binding is demonstrated for the CHRAC1-POLE3 heterodimer in the original
        publication. The complex binds naked DNA but not nucleosomes [PMID:10880450].
      action: ACCEPT
      reason: &gt;-
        DNA binding is experimentally demonstrated for the CHRAC1-containing
        heterodimer. While a more specific term (double-stranded DNA binding)
        would be preferable, the NAS annotation accurately reflects CHRAC1&#39;s
        DNA-binding capability.
      supported_by:
        - reference_id: PMID:10880450
          supporting_text: &gt;-
            two human histone-fold proteins form a stable complex that binds naked
            DNA but not nucleosomes

  - term:
      id: GO:0006338
      label: chromatin remodeling
    evidence_type: NAS
    original_reference_id: PMID:10880450
    review:
      summary: &gt;-
        Duplicate annotation of chromatin remodeling with NAS evidence. Already
        covered by IBA and IDA annotations for the same term.
      action: ACCEPT
      reason: &gt;-
        While redundant with other evidence codes, this annotation correctly
        reflects CHRAC1&#39;s role in chromatin remodeling as a CHRAC complex subunit.
      supported_by:
        - reference_id: PMID:10880450
          supporting_text: &gt;-
            HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and
            two novel histone-fold proteins

references:
  - id: GO_REF:0000002
    title: Gene Ontology annotation through association of InterPro records with
      GO terms.
    findings: []
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings: []
  - id: GO_REF:0000043
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword 
      mapping
    findings: []
  - id: GO_REF:0000044
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular 
      Location vocabulary mapping, accompanied by conservative changes to GO 
      terms applied by UniProt.
    findings: []
  - id: GO_REF:0000107
    title: Automatic transfer of experimentally verified manual GO annotation 
      data to orthologs using Ensembl Compara.
    findings: []
  - id: GO_REF:0000108
    title: Automatic assignment of GO terms using logical inference, based on 
      inter-ontology links.
    findings: []
  - id: GO_REF:0000114
    title: Manual transfer of experimentally-verified manual GO annotation data 
      to homologous complexes by curator judgment of sequence, composition and 
      function similarity
    findings: []
  - id: PMID:10880450
    title: HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 
      and two novel histone-fold proteins.
    findings:
      - statement: The paper identifies human CHRAC (HuCHRAC) containing 
          SMARCA5/SNF2H, BAZ1A/ACF1, CHRAC1 (p15), and POLE3 (p17)
        supporting_text: &gt;-
          the human homologues of two novel putative histone-fold proteins in Drosophila
          CHRAC are present in HuCHRAC
      - statement: CHRAC1 and POLE3 form a stable heterodimer that binds naked 
          DNA but not nucleosomes
        supporting_text: &gt;-
          two human histone-fold proteins form a stable complex that binds naked DNA
          but not nucleosomes
      - statement: The complex has ATP-dependent chromatin remodeling activity
        supporting_text: &gt;-
          HuCHRAC, a human ISWI chromatin remodelling complex
      - statement: CHRAC1 is a histone-fold protein, not an enzyme
        supporting_text: &gt;-
          two novel putative histone-fold proteins in Drosophila CHRAC are present
          in HuCHRAC
  - id: PMID:12434153
    title: An ACF1-ISWI chromatin-remodeling complex is required for DNA 
      replication through heterochromatin.
    findings:
      - statement: ACF1-ISWI complex is required for replication through 
          pericentromeric heterochromatin
        supporting_text: &gt;-
          an ACF1-ISWI chromatin-remodeling complex is required for replication through
          heterochromatin in mammalian cells
      - statement: ACF1 and SNF2H become enriched in replicating pericentromeric
          heterochromatin
        supporting_text: &gt;-
          ACF1 (ATP-utilizing chromatin assembly and remodeling factor 1) and an ISWI
          isoform, SNF2H (sucrose nonfermenting-2 homolog), become specifically enriched
          in replicating pericentromeric heterochromatin
      - statement: Depletion of ACF1 causes cell cycle delay in late S phase
        supporting_text: &gt;-
          depletion of ACF1 causes a delay in cell-cycle progression through the late
          stages of S phase
  - id: PMID:14759371
    title: The histone-fold protein complex CHRAC-15/17 enhances nucleosome 
      sliding and assembly mediated by ACF.
    findings:
      - statement: CHRAC-15/17 (CHRAC1/POLE3) facilitates ATP-dependent 
          nucleosome sliding by ACF
        supporting_text: &gt;-
          these histone-fold proteins facilitate ATP-dependent nucleosome sliding
          by ACF
      - statement: Direct interaction of CHRAC-15/17 with ACF1 is essential for 
          nucleosome sliding
        supporting_text: &gt;-
          Direct interaction of the CHRAC-15/17 complex with the ACF1 subunit is essential
          for this process
      - statement: CHRAC-15 (CHRAC1) is essential for interaction with ACF
        supporting_text: &gt;-
          CHRAC-15 is essential for interaction with ACF and enhancement of nucleosome
          sliding
      - statement: CHRAC-17 (POLE3) also interacts with p12 (POLE4) in DNA 
          polymerase epsilon
        supporting_text: &gt;-
          CHRAC-17 interacts with another histone-fold protein, p12, in DNA polymerase
          epsilon
      - statement: CHRAC-15/17 facilitates chromatin assembly by a mechanism 
          different from sliding
        supporting_text: &gt;-
          CHRAC-15/17, p12/CHRAC-17, and NC2 complexes facilitate ACF-mediated chromatin
          assembly by a mechanism different from nucleosome sliding enhancement
  - id: PMID:21516116
    title: Next-generation sequencing to generate interactome datasets.
    findings: []
  - id: PMID:25416956
    title: A proteome-scale map of the human interactome network.
    findings: []
  - id: PMID:31515488
    title: Extensive disruption of protein interactions by genetic variants 
      across the allele frequency spectrum in human populations.
    findings: []
  - id: PMID:32296183
    title: A reference map of the human binary protein interactome.
    findings: []
  - id: PMID:33961781
    title: Dual proteome-scale networks reveal cell-specific remodeling of the 
      human interactome.
    findings: []
  - id: file:human/CHRAC1/CHRAC1-deep-research-openai.md
    title: Deep research review of CHRAC1
    findings:
      - statement: CHRAC1 is a nuclear protein localizing to the nucleoplasm
        supporting_text: &gt;-
          CHRAC1 is an intracellular, nuclear protein. It lacks any signal peptides
          or transmembrane domains, and consistent with its role in chromatin dynamics,
          it localizes to the cell nucleus, predominantly in the nucleoplasm
  - id: file:human/CHRAC1/CHRAC1-deep-research-cyberian.md
    title: Cyberian deep research on CHRAC1 function
    findings: []

core_functions:
  - molecular_function:
      id: GO:0046982
      label: protein heterodimerization activity
    in_complex:
      id: GO:0008623
      label: CHRAC
    description: &gt;-
      CHRAC1 forms a stable heterodimer with POLE3 via their histone-fold domains.
      This dimerization is analogous to H2A-H2B and is essential for DNA binding
      and interaction with the ACF complex [PMID:10880450, PMID:14759371].
  - molecular_function:
      id: GO:0003677
      label: DNA binding
    in_complex:
      id: GO:0008623
      label: CHRAC
    description: &gt;-
      The CHRAC1-POLE3 heterodimer binds naked double-stranded DNA but not nucleosomes.
      This DNA-binding capability is essential for tethering the remodeling complex
      to chromatin [PMID:10880450].
    directly_involved_in:
      - id: GO:0006338
        label: chromatin remodeling
    locations:
      - id: GO:0005634
        label: nucleus

proposed_new_terms: []

suggested_questions:
  - question: Does CHRAC1 have any independent function outside of its role in 
      the CHRAC complex?
  - question: What is the precise stoichiometry of CHRAC1 in the CHRAC complex?
  - question: Are there tissue-specific or developmental roles for CHRAC1?

suggested_experiments:
  - description: &gt;-
      Structural studies (cryo-EM) of the complete CHRAC complex to understand CHRAC1&#39;s
      precise positioning and interactions
  - description: &gt;-
      CHRAC1-specific knockout/knockdown studies to distinguish its function from
      other
      complex components
  - description: &gt;-
      ChIP-seq of CHRAC1 to map genome-wide binding sites

status: COMPLETE
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>